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ABSTRACT 
 
Background 
The World Health Organization (WHO) estimates that 350 million new cases of curable sexually 
transmitted infections (STIs) occur each year. Prevention of STIs include both primary and secondary 
prevention strategies: sexual education, condom distribution, testing and treatment services. Sweden 
has a long tradition of widespread testing for Chlamydia Trachomatis (C.trachomatis), an opportunistic 
screening approach. Sexual education in school is mandatory and a national network of Youth Health 
Clinics (YHC) enables health care access for youth. Still, infection rates of C.trachomatis have increased 
over the past decades since opportunistic screening was introduced, and moreover continue to stay 
high. In addition, national surveys indicate low condom use among youth. 
 
The overall aim of this thesis was to look deeper into the screening services to understand why this 
approach does not seem to have the sought for effect and to compare the effectiveness of a mobile 
phone application to improve sexual health among youth of Stockholm County in addition to routine 
care offered at the YHCs.  
 
Methods and Results 
Study I: Register based study performed from data obtained from three laboratories in Stockholm 
County. All tests for C.trachomatis done at the YHCs in Stockholm over a three year period were 
included in the study. The aim of the study was to describe testing behavior for genital C.trachomatis 
among youth in Stockholm County. Specifically to (1) study positivity rates among single and repeat 
testers, (2) to estimate the incidence of repeat testing and the rates of infection on repeat testing 
episodes and (3) to estimate time to repeat testing and factors associated with repeat testing. In total 
65 951 persons underwent 119 699 tests. Repeat testing was found among 42% of all study participants 
included in the study (ranging from 2 to 18 tests). Higher rates of C.trachomatis among repeat testers 
compared to single testers were found at baseline, especially among men. Incidence of repeat testing 
was higher than previously reported. 
 
Study II: A qualitative study. We interviewed 15 repeat testers at the YHCs about motives behind 
testing repeatedly and subsequent sexual risk-taking. Data was analyzed using a constructivist grounded 
theory approach. We found that youth perceive repeated testing for C.trachomatis equally protective as 
using a condom. The testing episode, test result or encounter with the clinic personnel did not steer 
sexual health preferences towards more protective sexual practices. A major motivation for the 
retesting process was the fear of infecting a peer leading to social stigma. The results of this study 
provide new information that will allow the C.trachomatis screening programs to introduce more 
appropriate interventions for youth retesting frequently and to streamline routines. In addition, lessons 
learned from our study could be helpful in other screening programs with high re-testing rates. 
 
Study III: Interview study. Twelve health care providers in YHCs in Stockholm were interviewed to 
explore their views on the practice of youth repeatedly testing for C.trachomatis ‘to stay safe and clean’. 
A content analysis approach was used to analyze data. Health care providers’ expressed appreciation 
for the easy-access testing services, as it facilitated individual sexual health counselling. Testing without 
having time to interact and reflect together with the youth was not perceived as meaningful. Findings 
from this study could strengthen ongoing preventive work thus involving the experience and expertise 
of daily care youth health care provider’s.  
 
Study IV: Randomized controlled trial (RCT). We aimed to complement and strengthen primary 
prevention strategies using a mobile phone intervention, (mHealth) given their popularity with youth. 
Following focus group discussions with young people, we developed a youth friendly smart phone 
application. The aim was to increase condom use and promote safe sex. The effect of the intervention 
was evaluated in a two arm parallel group pragmatic RCT; "The MOSEXY trial” (MObile Phone 
intervention for SEXual health in Youth). At time of inclusion, consistent condom use was reported 
by 1/10 of participants. Condom use increased in both arms however with no differences between the 
groups. In addition, number of sexual partners, frequency of re-testing and occurrence of STIs did not 
differ among the groups. 
 
Conclusion 
On an individual level, easy and prompt access to testing services is important in order to interrupt 
transmission of STIs and treat infections. At the same time secondary prevention strategies must not 
undermine primary prevention strategies aiming to improve sexual health in means of avoiding 
infections by condom use. A mHealth intervention did not increase condom use among youth in our 
setting. However, mHealth for sexual health has the potential to reach large group of youth effectively.  
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1. BACKGROUND 
 
1.1 SEXUAL HEALTH  
 
“Sexual health is a state of physical, emotional, mental and social well-being in relation to sexuality; it is not merely the 
absence of disease, dysfunction or infirmity. Sexual health requires a positive and respectful approach to sexuality and 
sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, 
discrimination and violence. For sexual health to be attained and maintained, the sexual rights of all persons must be 
respected, protected and fulfilled.” (World Health Organization, WHO1). 
 
Sexual health is a broad and sometimes complex concept that spans over a lifetime of different needs, 
wishes, joy, disappointments, and risks. Among many things, sexual health depends on the individuals’ 
access to sexual health information and education, knowledge about risks, susceptibility to risk-taking 
consequences, and access to sexual health care services.2  
 
The focus of this thesis is sexual health in relation to sexually transmitted infections (STIs), and sexual 
risk-taking defined as behavior that increases the risk of contracting a STI among the youth population. 
 
1.2 SEXUALLY TRANSMITTED INFECTIONS 
 
1.2.1 Historical context: sexually transmitted infections and barrier protection 
Interpretations assert that STI epidemics are described already in the Old Testament. In ancient time, 
STIs were considered a punishment for inappropriate behavior or consequence of bad personal 
hygiene. Further evidence in literature originates from ancient Rome and Greece, and the medieval 
ages up until 15th century. Throughout this time period, STIs were not fully understood in terms of 
source of infections and infectivity, although theories of STIs relationship to sexual activity were 
emerging. Different symptoms were interpreted as variations and different stages of the same disease. 
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During the 15th and 16th centuries, a “new disease”, imported by Columbus, with severe symptoms 
spread quickly over Europe (syphilis), affecting people regardless of social status. Irrespectively 
excising taboos, sexual activity and prevention measures were discussed. Misinterpretations and 
misconceptions gave rise to many theories regarding STIs over the coming centuries. It was not until 
the achievements in microbiology in the late 19th and early 20th century that these misconceptions could 
be rejected.3    
 
Condom is a barrier method that can prevent unwanted pregnancy and STIs. Since ancient Egyptian 
times, penis protection has been used for the purpose of non-fertilization. Various materials were 
applied throughout history to attain the desired effect, such as linen, silk, and animal intestinal devices. 
In the 16th century, the Italian doctor, Gabriel Fallopius, described how men can protect themselves 
from venereal diseases by wrapping linen, preferable soaked in saliva, around their penises. It has 
further been described that he tested “the condom” in 1100 men, of whom none contracted syphilis. 
At the end of the 19th century, condoms of raw rubber were manufactured, and when large-scale 
production of thin latex was possible the 1930s, the condom became increasingly popular.4 5 
 
   
Figure 1. History of the condom (Image source: Historical Museum at Lund University, Sexinfo-online 
University of California,4 permissions obtained) 
 
1.2.2 The global burden of STIs 
STIs, also referred to as sexually transmitted diseases (STDs), are transmitted from one person to 
another through sexual contact, and are caused by bacteria, viruses or parasites. Mother to child- and 
blood transmission, are other routes of STI transmission. STIs primary affects the genitals, the 
reproductive tract, the urinary tract, the oral cavity, and/or the rectum.6  
 
3 
 
STIs are caused by more than 30 different pathogens among which eight are most prevalent worldwide. 
These are: Hepatitis B, Human Immunodeficiency Virus (HIV), herpes, Human Papilloma Virus 
(HPV) which are viral STIs, and chlamydia, gonorrhea, syphilis, trichomonas which are non-viral and 
curable STIs. Globally, more than 400 million people carry genital herpes, and more than 290 million 
women have an HPV infection. WHO estimates that 350 million new cases of curable STIs (chlamydia, 
gonorrhea, syphilis and trichomonas) occur each year.6 
 
Given the magnitude, the burden of STIs is borne at all societal levels. At individual level, STIs can 
cause mortality and morbidity, besides social stigma. Individual-based interventions aim to reduce 
morbidity/mortality and improve management through counselling, distribution of condoms, tests, 
vaccines, and treatment. Partner centered interventions aim to reduce transmission through partner 
notification and partner treatment. At a population level, interventions should aim to prevent or 
mitigate an epidemic through primary prevention programs, population screening, and vaccination 
programs. STI related interventions are widely described however, despite this, not available to 
everyone globally.7 The setting of this thesis is a high income country where STI prevention strategies 
are available at individual-, partner-, and population level.    
 
1.2.3 Chlamydia Trachomatis: situational analyses globally and in Sweden 
Genital Chlamydia trachomatis (C.trachomatis) is the most commonly reported STI worldwide and is 
considered a major public health problem.6 C.trachomatis can cause severe subsequent complications 
including pelvic inflammatory disease (PID), which in turn can lead to tubal factor infertility, ectopic 
pregnancy, preterm birth and recurrent spontaneous abortions (Figure 2).8-10 In addition, C.trachomatis 
increases susceptibility to HIV infection.11 12 C.trachomatis can ascend to the upper genital tract in men,  
complications for women are more common and more severe.13 
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Figure 2. Histology and possible health complications of C.trachomatis (Image source: STI: challenges 
ahead, Lancet, 201714 and European Centre for Disease Prevention and Control. Guidance on chlamydia control in 
Europe – 2015. Stockholm: ECDC; 201615, permissions obtained). 
 
Symptoms for women might include increased or altered vaginal discharge, bleeding between periods 
or after intercourse, burning sensation/pain during urination, and/or lower abdominal pain.16 Men 
might experience discharge from the urethra, burning sensation/pain during urination and/or pain in 
the testis.17 Most cases (up to 80%) of C.trachomatis remain asymptomatic.18 19 
 
Women account for the majority of reported infections. Approximately 57% of all cases in Sweden, 
and in Europe, are in  women,20 21  while the corresponding figure for the US is 66%.22 In 80% of all 
reported cases heterosexual transmission is reported.20 21 
 
An objective comparison of C.trachomatis incidence between countries is difficult as reporting practices 
and national screening practices vary widely.15 In the US, 528 cases per 100 000 population were 
reported in 2017,22 in Australia the corresponding number was 379/100 000 (2017).23 Among 
European countries, who reported high figures in  2016 the UK had 350/100 000 cases, Sweden 337, 
Norway 478, Denmark 573, and Iceland 650/100 000.21  
 
Prevalence point estimates from population based studies vary largely depending on country, age 
group, sex, population coverage and risk-group. In population-based surveys among sexually active 
youth < 26 years old, C.trachomatis prevalence range from 3.0% to 5.3% for women, and from 2.4% to 
7.3% for men.24 In Australia the estimated prevalence is 5.0%,25  and a national based study from the 
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Netherlands estimated a prevalence of 2.8% (1.1% in men and 5.6% in women) in ages 18-34.26 In 
2012 the global prevalence was estimated to 4.2% in women and 2.7% in men.27 
 
The incidence of genital C.trachomatis in Sweden is considered high. In 2018, there were 32006 new 
infections reported in the country. Since 1995 there has been a steep increase in C.trachomatis incidence, 
however it seems to now have stabilized at a high level. There has been a slight decrease in total number 
of reported cases over the past 3 years since this thesis work began (Figure 3) but the reason for this 
is not established.20 While increasing rates of reported C.trachomatis cases can be attributed an actual 
increase in incidence and sexual risk-taking, more sensitive tests, and/or increased case finding 
practices,28 the opposite could apply for the current stable/slightly decreasing rates of C.trachomatis.21-23 
 
The increase in reported cases during 2007-2008 represent a mutated form of C.trachomatis, discovered 
first in 2006, but firstly detectable in laboratories the following years (Figure 3).20 Of all tests in Sweden 
6-7% were positive (2009-2018).20 Calculated prevalence in STI clinical settings is reported at 
approximately 11 %.29 30  
 
 
Figure 3: Number of reported cases of C.trachomatis in Sweden between 1992 and 2018.20 
 
 
Globally, adolescents and young adults are disproportionally affected by C.trachomatis.21 In Sweden, 
people aged 15-19 account for approximately 25% of all reported infections, people aged 20-29 
account for approximately 60%, and for 30-39 year old 12% (Figure 4).20 Young women represents a 
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higher proportion of C.trachomatis in the younger age groups, i.e. 15-19 and 20-24, whereas rates among 
men are higher for those age 25 and older.21 In this thesis, we will focus on sexual health and 
C.trachomatis, which is often described as a marker for sexual risk taking,31 and prevention among youth. 
 
Youth are defined by the WHO as people aged 15-24.32 This thesis was conducted at the Youth Health 
Clinics (YHCs) where people aged 12-23 are received.33 Youth will here be referenced as a person 
visiting the YHCs for sexual health related issues, and while the mean age for first sexual intercourse 
in Sweden is 16 years,34 our definition will imitate the WHO definition.  
 
 
Figure 4. Proportion of reported C.trachomatis cases by age group.20 
 
 
1.3 SEXUAL RISK-TAKING 
 
1.3.1 Sexual behavior of youth in Sweden 
Risky sexual behavior includes sexual activity at an early age, having multiple sexual partners,  
concurrent partners, having sex while under the influence of alcohol or drugs, and unprotected sex 
(i.e. without condom or other contraceptives) with a new of temporary partner.35-38 Predictors of sexual 
risk-taking have been widely studied and both individual- and family determinants have been 
described.39 At an individual level, younger age at sexual debut predicted sexual risk-taking, at family 
level growing up with a single parent predicted early sexual debut.39 Specific predictors of C.trachomatis 
acquisition for young women were number of partners and having been (financially) reimbursed for 
0
10
20
30
40
50
60
70
P
ro
p
o
rt
io
n
  o
f 
re
p
o
rt
ed
 c
as
es
 %
 
Reported C.trachomatis cases by age group
Age 15-19 Age 20-29 Age 30-39
7 
 
sex. In men, the strongest predictors were number of partners and level of alcohol consumption.37 
Additionally, C.trachomatis infections has also been associated with social-economic disadvantages, and 
belonging to minority ethnic groups.40 41 
 
Young people’s sexual habits have repeatedly been explored in Swedish surveys and studies.42 34 43 
Sexual risk-taking among youth in terms of having multiple sexual partners and a more liberal view on 
sex outside a stable relationship, has significantly increased over the last decades.44 45 46 More so, people 
have children later in life, thus the period of exposure to sexual risks and sexual risk-taking has 
increased.47  
 
Although knowledge and confidence in condoms as an effective way of preventing STIs has increased, 
this has not resulted in more widespread use.34 42 48  In a large national population based study (2007) 
involving 20 000 men and women aged 18-30, 50% of women and 40% of men, stated that they never 
or seldom used condoms with a temporary partner.49 A national survey among youth aged 15-29 
(UngKAB09, 2009)  reported 70% frequency of not using a condom at the last intercourse, and 50% 
said they did not use a condom with a new partner at the last intercourse.42 When the study was partly 
replicated six years later (UngKAB15, 2015), 25% stated that they used a condom continuously during 
their latest intercourse, however this result included all participants, not only those with a new or 
temporary partner at last sexual encounter.34 Although the proportion of intercourses with a condom 
is considerably low, interestingly 89% of youth stated that they would not have had any problems 
suggesting a condom at their last intercourse.34 
 
Regardless of the high proportion of non-condom users, the percentage of youth who perceive 
themselves at risk of STIs is low. In a study among sexually active youth aged 15-24, 46% stated they 
were at no risk of an STI whereas 31% said they perceived a little risk being infected by a STI.43 In a 
population based study including those without sexual experience, 71% perceived themselves at little 
or no risk of contracting STI.42  
 
In general youth are much more worried about unwanted pregnancy than STIs.43 Approximately 60 % 
of young women aged 15-24 declared that they were using contraceptives (most commonly 
contraceptive pills) other than a condom at their last intercourse. Six percent, used a condom in 
combination with another contraceptive method .43 Increased use of non-condom anticonception  over 
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the past years43 is indeed encouraging, however from the perspective of STI reduction, dual protection,  
also referred to as the “double Dutch approach”, i.e. combining contraceptives with condoms – is 
more appropriate.50  
 
1.3.3 Condom use and condom failure 
Failure to use condoms has been the focus of many studies. A condom can be considered embarrassing 
to mention, awkward to use, and costly.51-54 Other important factors that affect condom use are: 
influence of alcohol or drugs, fear of losing erection; sensation reduction, a sense of ‘will not happen 
to me’ attitude, forgetfulness (easy to forget in the heat of the moment), interference with spontaneity, 
waiting for sexual partners to be “condom promoters”, the use of other contraceptives, and peer habits 
and behaviors.51-55 Young people also report not being prepared for the situation, i.e. they did not bring 
a condom while  others report insecurity about how to use a condom.43 Reasons for not using condoms 
are thus many and well known.  
 
1.4 PREVENTION OF C.TRACHOMATIS 
 
1.4.1 Primary prevention strategies for C.trachomatis in Sweden 
Primary prevention strategies include activities aimed at preventing new cases through health and 
sexual education, sex-health promotion campaigns as well as condom promotion and distribution 
(Figure 5). In Sweden, sexual education is part of the elementary school curriculum. From the age of  
10 years, and throughout compulsory school, sexual education is embedded into different school 
subjects.56 Additionally, the national Swedish network of YHCs plays an essential role in primary 
prevention strategies for STIs. Sexual health and personal development throughout the youth period  
is the main focus of the YHCs.57 Despite school strategies, youth rates the internet as the first source 
of information regarding sexual health after friends and YHCs.34 
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Figure 5. Primary and secondary prevention for C.trachomatis (Image source: (Image source: STI: 
challenges ahead, Lancet, 201714 and European Centre for Disease Prevention and Control. Guidance on chlamydia 
control in Europe – 2015. Stockholm: ECDC; 201615, permissions obtained). 
 
1.4.2 Secondary prevention strategies C.trachomatis  
Secondary prevention of C.trachomatis aims to prevent transmission to a sexual partner and reduce risk 
of negative consequences of an infection by testing, treatment and partner notification (Figure 5). 
There are large differences in C.trachomatis control policies across Europe and worldwide. The guidance 
for Chlamydia Control published by the European Center for Disease Prevention and Control (ECDC) 
aims to support member states to implement and/or improve national strategies for C.trachomatis built 
on the capacity of the different national health care systems.15  
 
Across Europe the organization of C.trachomatis control range from being nonexistent to large 
population screening programs.58 National screening is available only in one country in Europe, the 
UK.59 The opportunistic screening approach includes case finding (including contact tracing) and 
offering testing to one/more than one specific group of asymptomatic people (e.g. pregnant women 
or youth) (Table 1).15 Over the past decade, C.trachomatis control activities has strengthened in Europe 
and most countries report primary prevention activities in addition to case management guidelines and 
partner notification (Category 3, Table 1).60  
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Table 1: Categories of C.trachomatis control activities in Europe (ECDC61) 
Category Criteria 
1. No organized control activity No national guidelines for C.trachomatis diagnosis 
and treatment 
 
2. Case management Guidance on C.trachomatis diagnosis/treatment to 
at least 1 group of health care professions 
3. Case finding Case management guidelines and partner 
notification 
 
4. Opportunistic screening Case finding and testing offered to at least one 
group of asymptomatic people. 
5. Screening programs Organized C.trachomatis screening to a substantial 
part of the populations   
 
 
 
1.4.3 Opportunistic screening for C.trachomatis in Sweden 
Guided by national laws and regulations,62 63 regional policies control the preventive work in the 
different County Councils in Sweden.64 Sweden has a long tradition of widespread testing. An 
opportunistic screening approach was introduced already in 1982 offering C.trachomatis testing to 
women requesting contraceptives, antenatal care or abortion Male partners of infected women were 
also tested thru contact tracing.65 66 In the late 80s the infectious disease law was changed and came to 
include free testing and treatment of C.trachomatis, partner notification and case reporting.63  
 
The number of reported cases of C.trachomatis decreased in Sweden up to the mid-1990s (Figure 3).65-
67 However, the decline during this period also coincided with the national HIV prevention 
campaigns.68 Despite this initial positive effect of widespread testing, and  national efforts as availability 
of testing and treatment services, the number of reported C.trachomatis cases in Sweden has, over the 
past two decades, steadily increased and has now stabilized at a high level.20  Nevertheless the Swedish 
opportunistic screening program including availability of widespread testing to asymptomatic persons, 
the infectious disease law which enabled free testing and treatment and partner notification, has been 
held up as an example of success in relation to C.trachomatis control.69  
 
1.4.4 The effectiveness of screening for C.trachomatis on prevalence and sequelae  
Screening for C.trachomatis aims at controlling the transmission, reducing infection prevalence, and 
thereby reducing the risk of severe reproductive complications such as PID and tubal factor infertility 
11 
 
(Figure 2).59 Numerous studies as well as policy documents conclude that increased testing coverage 
and re-testing is important to halt the C.trachomatis epidemic.70-73 However, while more and more 
countries introduce different levels of C.trachomatis control strategies and screening programs there is 
an ongoing debate about the benefits of such programs, 13 69 74 75 both regarding cost-effectiveness,19 76-
78 and the fact that C.trachomatis associated complications might be lower than previously expected.75 79-
82  
 
The Netherlands stopped a pilot national screening program in 2012 after a trial showing no statistical 
evidence of impact on C.trachomatis positivity rates or estimated population prevalence from the 
C.trachomatis Screening Implementation programme.83 Although difficult to compare, (due to different 
methodologies), in the UK population based prevalence has not changed between 1999-2000 and 
2010-2012, i.e. before and after the rollout of the national screening program.84  More so, national 
representative studies on C.trachomatis prevalence, indicate no differences between countries with 
screening programs and those without.40 84-90 Hence, the evidence of the impact of opportunistic 
screening and screening programs is limited and there is no conclusive evidence of the impact of such 
programs in reducing infection of C.trachomatis at a population level.61 83 84  
 
While it is clear that the incidence of PID in the population has decreased during the last 20-35 years 
it is not possible to determine to what level this was an effect of scaling up C.trachomatis prevention 
programs.78 In fact, PID has generally decreased in a variation of countries, regardless if widespread 
testing /screening is present or not.14 No long-term effects of intensified screening were found in 
terms of reduced reproductive consequences from a 9 year follow up Danish study.82  
 
A recently published Dutch study found considerably higher risk for both PID and tubal factor 
infertility among women who previously experienced C.trachomatis.91 Nevertheless, the overall incident 
of sequelae was low, only 1% of women experienced tubal factor infertility over an 8-year follow-up 
period. Given the low cumulative risk of sequelae, and the lack of evidence that screening affects 
prevalence, the authors suggests that focusing on women with risk of complications would be more 
feasible than widespread testing and screening.91 Evidence to support a shift from focusing on 
screening to improved management of diagnosed cases and sequelae were previously presented.14 For 
ectopic pregnancy, no elevated risk for those who previously experienced C.trachomatis was found.91 
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Despite the above, widespread testing, opportunistic screening and national screening are advocated 
as efficient methods to tackle the C.trachomatis epidemic.38 70 Lack of beneficial evidence is said to derive 
from insufficient screening uptake in the populations, and outcome measure (prevalence) studied.92 
Mathematical models estimated that annual screening coverage of the target population of 30% or 
more, could decrease C.trachomatis prevalence.93 94  
 
1.4.5 Population coverage: number of tests/tested persons and number of positive cases  
Voluntary yearly reporting from the laboratories in Sweden to the Public Health Agency indicates an 
increase in number of tested persons/tests for C.trachomatis over the past two decades (Figure 6). 
Double reporting can possibly occur in the numbers reported from the laboratories.20 Furthermore, 
some reports does not differentiate between persons tested and tests, i.e. ten tests can in fact constitute 
of less than ten unique individuals testing repeatedly over the year, and thus population coverage is 
hard to determine. 
 
 
Figure 6: Number of tests/tested persons and number of positive Chlamydia cases. 1992-2017.20 
 
The mandatory reporting of a positive C.trachomatis test in Sweden gives a close to accurate information 
about who is infected (i.e. age, sex, domestic or foreign source of infection and homo- or heterosexual 
transmission of infection).63 The population coverage for testing and the frequency of re-testing is less 
studied. In a study conducted at a STI clinic in Stockholm, 82% of the clients (20-40 year old) reported 
having tested for C.trachomatis before, and 43% reported having been tested for C.trachomatis in the 
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previous 12 months.29 This indicates that a significant proportion of tests are being done in the same 
persons. A study from New Zealand found that repeat testing was common and that estimates of 
population coverage by test overestimated individual coverage.95 Similar finding were reported from 
the UK.73  
 
1.4.6 Repeat testing related to risk of re-infection 
Re-infection of C.trachomatis is common.96 Re-infections has been described to increase the risk of 
severe consequences.81 97 In different studies, approximately one of four women treated for 
C.trachomatis, were diagnosed again within one year.98 99 Most re-infections origins from new infection 
with a new partner.96 Recommendations to re-test within 3-6 months after an infection exists in some 
countries including US, Canada, UK, and New Zealand.38 59 100 101 According to a mathematical model, 
a re-test within 2-5 months might be efficient in detecting new infections.102 Annual screening for 
young people under the age of 25, is recommended in several countries including the US, Australia, 
Canada, and UK.14 38 59 100 Sweden has no official policy for re-testing although The National Plan for 
Chlamydia Prevention (launched in 2009), recommended testing for those who exposed themselves to 
risk, and re-testing within six months for those with an elevated risk of C.trachomatis.103 
 
1.4.7 Test and test results effect on sexual behavior  
With an increasing number of C.trachomatis tests performed in Sweden, across Europe and elsewhere, 
it is important to understand if and how a test episode, and the test result affect the individual’s future 
testing and sexual behavior. Approximately 450 000 tested persons/tests performed in Sweden per 
year (Figure 6) with an overall positivity rate of 6-7%, implies high numbers of negative test results.20 
In addition to clinical visits, on-line testing is increasingly popular.104  
 
Existing evidence, although scarce, suggests that a positive test result of an STI might affect sexual risk 
taking towards a more protective attitude, at least in the short term.105 106 Importantly negative STI test 
result on the other hand seems to have no effect on subsequent risk taking.106 There are even studies 
that indicate that a negative test result has a negative effect on behavioral changes, i.e. adopting more 
risky sexual practices.107-110 A phenomenon referred to as “unintended screening effect” has been 
described in the literature,109 where a negative STI diagnosis is reported to result in creation of 
complacency about the importance of engaging in safer sexual practices. Similar findings were reported 
among young people in Sweden. Women described repeatedly testing for STIs to assure a disease-free 
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status. A negative test result did not change the women’s behavior but rather confirmed to them that 
sex without a condom was not overly risky.110 How a test episode, and the test result affect the 
individual’s future testing and sexual behavior is studied in this thesis. 
 
As described above, primary and secondary prevention should complement each other (Figure 5). 
However, it has been described that secondary prevention strategies tend to be prioritized over primary 
prevention.111 Explanations for the focus on testing, treatment, and contact tracing could possibly be 
that such interventions are less time consuming, both for the health care providers and for the 
individual. Additionally, the effect of secondary prevention are easy to measure on an individual level, 
i.e. you are diagnosed and subsequently treated and cured. Furthermore, it might be perceived as easier 
to test than to change behavior (using a condom).  
 
1.5 SEXUAL HEALTH INTERVENTIONS 
 
It is indeed important that young people who expose themselves to risky sexual behavior test 
frequently. In addition to providing testing services, it is also desirable that caregivers uses the 
opportunity to guide testers towards a more protective behavior, i.e. primary prevention strategies. 
According to Swedish youth, approximately 50% who tested stated they had received primary 
prevention counselling.34 It has also been reported that youth, testing for STIs, found talking about 
sexual practices in a face-to-face session with a caregiver, embarassing.112  
 
Many studies have focused on finding and evaluating how to best tailor sexual health interventions.107 
113-117 Methods used, theoretical framework, and the effect of interventions vary.118 Educational 
interventions has shown positive results in terms of increased knowledge regarding STIs, as well as 
attitude changes.53 However, increased knowledge about STI does not necessarily translate into a 
positive impact on behavior (increased condom use, reduction in sexual partners).119 School-based 
behavioral interventions tailored to improve and maintain safe sex behavior among youth showed 
improved knowledge and improved self-efficacy, however did not affect risk-taking or infection rate.116  
 
During the last decade, sexual health interventions has focused on behavioral change interventions.120 
Motivational Interview (MI) to change sexual risk-taking was assessed in Sweden. Brief MI counseling 
significantly reduced the incidence of C.trachomatis and risky sexual behavior among women.121 One 
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meta-analysis including over 50 000 patients showed a significant reduction of STIs in the group 
receiving single session behavioral intervention.122 On the other hand, a systematic review was unable 
to detect strong evidence for the effectiveness of condom promotion interventions.123 
 
In the WHO publication “Brief sexuality-related communications: recommendations for public health approach” 
(2015),2 different behavioral change interventions were reviewed, and recommendations for 
promotion of sexual health using brief counselling were outlined. Most counselling interventions aimed 
to support young people to re-formulated emotions, their thoughts and eventually behavior by using 
a patient/client centered approach (for instance MI). In studies reviewed, it was found that brief 
counselling can improve consistent condom use,113 124 increase sexual health knowledge,125 and reduce 
STI prevalence.126 Evaluated interventions involved both group counselling127 and individual 
counselling, where individual counselling was found more efficient.2 Single session interventions were 
found just as efficient as reoccurring sessions.124-126  
 
A subsequent systematic review further explored brief counselling interventions with focus on the 
behavioral change techniques.118 The most prevalent theoretical framework used were MI and 
Information Motivation Behavioral Skills Model of Behavioral Change. Among 85 reviewed studies, 53 were 
found efficient. In total, 48 different behavioral change techniques were identified including problem 
solving, feed-back on behavior, and information about health-social-and- environmental consequences. Hence, the 
authors conclude that a wide range of behavior change interventions can efficiently be used to tackle 
sexual risk-taking.118 
 
1.6 MHEALTH TO IMPROVE SEXUAL HEALTH 
 
It can be argued that scaling up of successful MI techniques and other forms of face-to-face counselling 
are time consuming, and may not be feasible for already time-constrained health care providers to 
implement. Thus, new innovative ideas to promote safe sex among youth are needed. 
 
mHealth, an abbreviation for mobile health, is a term used to describe the practice of medicine and 
public health supported by mobile devices.128 The use of mobile phone technology is an increasingly 
popular and relatively inexpensive way to reach large groups of the population to improve health 
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outcomes including sexual health, it can serve to complement ongoing activities within the health care 
system.119 129-131 132 
 
mHealth interventions is particularly suitable for youth and sexual health promotion as the intervention 
is delivered in a familiar, and discrete way to at-risk population.133 mHealth also offers the possibility 
of a range of different interventions for example reminder (to use a condom or to test), and 
motivational messages.128 Furthermore the coverage of mobile phone ownership among young people 
in Stockholm County is high. Among the whole population in Sweden 97% own a mobile phone and 
the majority of these are smart phones.134 
 
During the last decade youth targeted sexual mHealth interventions has been developed and 
evaluated.130 135 Results from studies are diverse and somewhat conflicting. Using text-messages as a 
way to change behavior (in reducing the number of partners) were found effective in a randomized 
controlled trial in Australia.136 STI prevention messages via Facebook, on the other hand, did not 
increase condom use over time, however prevented a decrease in condom use compared to the control 
group.137A systematic review found evidences that text message interventions increased adherence to 
antiretroviral medication in low-income.138 Another systematic review of randomized controlled trials 
(RCTs), found that mHealth interventions for sexual health, increased knowledge regarding STIs, 
increased re-testing after C.trachomatis infection, and increased clinic attendance. The review comprised 
of ten RCTs, even though there were promising results, no significant changes in sexual risk behaviors, 
i.e. condom use was found.128 A subsequent, more recent meta-analysis of mHealth interventions to 
reduce STIs, found a significant improvement of condom use, safe sex knowledge, and delay of sexual 
activity.135  
 
Thus far, evaluations has foremost involved interventions delivered via e-mail, websites, social media, 
text messages to forward sexual and reproductive health information, and text-and voice message 
reminders.128 135 139-143 A smart phone application (app) on a mobile device allows for more dynamic 
engagement and interaction between the user and the technology.144 145  
 
Existing mobile phone apps for STI prevention and care were reviewed using app-store/google plays, 
showing that most available apps had failed to attract user attention.145 This result emphasizes the need 
to involving targeted population in the development of the app. Except a qualitative evaluation of a 
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website for preconception health, 146 there has not been evidence from Sweden on the use of mHealth 
interventions to promote safe sexual practices among the youth.  One of the studies in this thesis 
evaluates the use of a mHealth intervention on promoting safe sex among the youth.  
 
1.7 THE IDEAS BEHIND THE ORIGIN OF THIS THESIS 
 
This project is deeply rooted in the everyday clinical practice at the YHCs. In my role as a midwife at 
a centrally situated YHC in Stockholm, I meet 50 youth per week, the whole clinic receives 
approximately 6000 youth aged 12-23 each year. The causes of contact usually included contraceptive 
counselling, physical examinations, sexual health related counselling, and STI testing, treatment and 
contact tracing. Youth come for booked appointments (30-60 minutes), or drop-in appointments (10-
15 minutes).  
 
Informal discussion with colleagues regarding prevention strategies for STIs often took place during 
the coffee and lunch breaks. We experienced increasing demands from the health care system on 
accessibility and effectivity (meeting more youth) and we started to question the focus on secondary 
prevention strategies and whether these efforts would bring down C.trachomatis incidence. Reported 
high rates of C.trachomatis among our target group suggested efforts were not sufficient or needed to 
be re-focused. Additionally, when meeting youth who came to test, it occurred to me again and again 
that they seemed to be relying completely on the secondary prevention offered to them. Quotes like 
“I test, therefore I am safe” made me interested in the accessibility of testing services and how that might 
possible affect risk-taking.  
 
I articulated a group of potential problems and research questions: What do we actually know about 
youth coming to the clinic? How often do they come? How often do they change clinics? How often 
do they test? How are they affected by the test result? Are our efforts to reach these youth with primary 
prevention strategies upon visiting the clinics doomed to fail?  
 
Discussions continued among colleagues: if what we are doing today is not enough to affect sexual 
health among youth, then how can we strengthen our methods? It is my strong belief that all employees 
at the YHCs have a genuine wish to improve sexual health among youth, thus focusing on secondary 
preventions is not always satisfactory. However, with structural constraints within the health care 
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system, new innovating ways to promote preventive work seemed essential. Using mHealth for this 
purpose was discussed and perceived as feasible. mHealth offers the potential of delivering primary 
prevention information independent of health care providers available time.  
 
Working with youth at the YHC, and in addition the many interesting and engaging discussions and 
debates with colleagues, inspired me and spurred the ideas which came about in this thesis.  
 
1.8 THEROETICAL FRAMEWORK 
 
1.8.1 Health care utilization model 
The Andresen’s Health Care Utilization Model, was chosen to conseptualize this thesis.147 The adapted 
phase four model,148 describes a number of interacting dynamics and areas influencing health service 
utilization (Figure 7). These are: 
 
 Environment which includes the health care system (YHCs), mHealth services, and 
additionally sexual education in school.   
 Population characteristics including the predisposing factors (sex, age, relationship status, 
and health beliefs) the enabling factors (support from peers/family, availability and accessibility 
to health care in the community), and needs (perceived and actual need to use health care 
services).  
 Health behavior includes personal health practices such as safe or unsafe sexual practices, 
and use of the health care system for example STI testing and visits at the YHC.  
 Outcome includes both objective health status (for example test result) and perceived health 
status (perceived risk and perceived severity of the possible outcomes, i.e. STI infection) but 
also “customer” satisfaction of the health care visit.  
 
All four sub-studies move across these interacting areas. Study I specifically addresses the environment 
and the accessibility to health care in relation to testing services and additionally the population 
characteristics. Study II and III clearly refers to all above described dynamics by exploring the how 
accessibility to health care, and subsequently the outcomes affects health beliefs and health behavior. 
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In Study IV we explore the dimension of mHealth in relation to predisposing characteristics and the 
health behavior. 
  
 
Figure 7. Health care utilization model (Figure adapted from Andersen Phase four model 148). 
  
1.9 SUMMARY 
 
In summary; the best strategies to control C.trachomatis are yet to be defined.6 Significant efforts to 
reduce C.trachomatis among youth has not resulted in sough after effect. Information on who is using 
the testing services and how frequently they do so, is essential to make correct assumptions regarding 
incidence, prevalence, and opportunistic screening coverage in the population. Furthermore, increased 
knowledge about who is using the testing services, the extent of re-testing, reasons for re-testing, and 
how test results impact on sexual risk-taking will have implications for planning and implementing 
interventions to lower the incidence of C.trachomatis. High rates of C.trachomatis among youth together 
with reports on low condom use, indicates that testing and treatment services need to be 
complemented with a stronger emphasis on safe sex. mHealth interventions targeted to youth could 
potentially promote sexual health and needs exploration in Sweden.  
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2. AIMS  
 
The aim of this thesis was to study the testing behavior for C. Trachomatis at the Youth Health Clinics 
in Stockholm County and to evaluate a mHealth intervention to support safe sexual practices among 
youth. With regard to testing behavior, this thesis focuses specifically on the testing episodes and test 
results influence on future testing behavior and sexual risk taking. It further explores this qualitatively 
with youth and health care providers at Youth Health Clinics.   
 
Specific aims were 
To describe the testing behavior for genital C.trachomatis among youth in Stockholm County, with a 
focus on repeated testing.  
 
To explore the motives for repeat testing for C.trachomatis among youth, and how testing affects 
subsequent sexual risk-taking 
 
To explore health care providers’ perception of youth testing repeatedly for C.trachomatis in Stockholm 
County 
 
To evaluate the effects of a mobile phone intervention (mHealth) designed to promote safe sexual 
practices and improve condom use among sexually active youth in Stockholm County. 
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3. METHODS 
 
3.1 STUDY SETTING 
 
3.1.1 Stockholm County 
The setting of the studies were the YHCs in Stockholm County, Sweden. Stockholm County is divided 
into 26 municipalities, rural and urban, and spread over an area of 6526 km2.149 (Figure 8.) The total 
population is 2 303 417 (2017), and youth aged 12-23 account for 13.2 % (303 595) of the population.150 
 
Figure 8. Stockholm County, 26 municipalities, location in Sweden (Image Source: National 
encyclopaedia149) 
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3.1.2 Youth Health Clinics 
The first YHC was launched in the 70:s Borlänge, Dalarna,57 and the Association of Swedish YHCs 
was founded in 1988.  Health care for young people is provided free of charge to the user in Sweden. 
This includes services accessed at the YHCs.151 The national association of YHCs comprises 
approximately 220 clinics, and in Stockholm County there are 33 YHCs.33 152 The last available report 
from YHCs in Stockholm County (2014), indicates 113000 annual visits were made by approximately 
56000 unique visitors.33 The 33 YHCs in Stockholm are situated in different districts and/or 
municipalities. Youth can access any preferred YHC.  
 
Historically, due to increasing abortion rates, the clinics were focused on preventive work related to 
unwanted pregnancies, and abortion consultation. The AIDS epidemic in the mid-80s led to an 
increased focus on primary and secondary prevention of STIs. This included sexual education to 
individuals and groups such as school classes, condom information and distribution, as well as testing 
and treatment services.57 149 152  
 
The YHCs receives youth ages 12 to 23. Apart from focus on sexual health and relationship related 
issues, the YHCs also provides individual and group guidance/counselling regarding lifestyle, personal 
development, mental health, and social problems. The YHC staff constitutes of nurse/midwives, 
behavioral therapists, social workers and physicians.  
 
3.1.3 C.trachomatis in Stockholm County  
The highest infection rate of C.trachomatis in Sweden is reported from Stockholm County with an 
incidence rate of 383 cases/100 000 inhabitants. In total, 8847 cases of C.trachomatis were reported to 
the authorities in 2018.20  Heterosexual transmission is the most common way of contagion (88%), and 
more than half (53%) of reported cases appears in females.153 In the country, 80% of all cases are found 
in  aged 15-29.20 Overall approximately 140 000 of all tests for C.trachomatis are annually done in the 
County,153 and 40000 of these come from the YHC in Stockholm.154 Of all positive tests in Stockholm 
40% are reported from the YHC.153  
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3.2 STUDY OVERVIEW 
 
The thesis comprises four studies and includes both quantitative (Study I and IV) and qualitative 
approaches (Study II and III). An overview of the methodology of the four studies is presented in 
Table 2. 
 
Table 2. Overview of methodology study I-IV 
 Study I Study II Study III Study IV 
Study aim To describe the 
testing behavior 
for genital 
C.trachomatis 
among youth in 
Stockholm 
County, with a 
focus on repeated 
testing. 
To explore the 
motives for 
repeat testing for 
C.trachomatis 
among youth, 
and how testing 
affects 
subsequent 
sexual risk-taking 
To explore health 
care providers’ 
perception of 
youth testing 
repeatedly for 
C.trachomatis in 
Stockholm 
County 
To evaluate the 
effects of a 
mobile phone 
intervention 
(mHealth) 
designed to 
promote safe 
sexual practices 
and improve 
condom use 
among sexually 
active youth in 
Stockholm 
County. 
Study design  Retrospective 
register based 
cohort study 
Qualitative 
interview study 
Qualitative 
interview study 
Pragmatic 
randomized 
controlled trial 
Timeline of 
data collection 
December 2013 
to September 
2015 
April 2015 to 
April 2016 
August 2016 to 
March 2018 
October 2017 to 
October 2018 
Study 
population 
All youth 
(n=65 951) who 
tested for 
C.trachomatis in 
any of the YHC 
in Stockholm 
County between 
1 of January 2010 
to 31 of 
December 2012. 
Heterogeneous 
sampling, 15 
repeat testers. 
Youth aged > 18 
who attended the 
YHC and had 
tested for 
C.trachomatis >2 
during the past 6 
months. 
Heterogeneous 
sampling, 12 
health care 
providers at 10 
different YHC in 
Stockholm 
County.  
433 youth aged 
>18 who 
attended the any 
of the 8 
participating 
YHC and had 
had >2 sexual 
partners during 
the past 6 
months. 
Data analysis Descriptive 
statistics and 
survival analysis 
Constructivist 
grounded theory 
Content analysis Descriptive 
statistics and 
regression 
analysis 
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3.3 STUDY METHODOLIGIES 
 
3.3.1 Study I 
Study design and population:  
Retrospective cohort study. All youth who came to test in one of the 33 YHCs during 2010-2012 were 
included in the study.  
Data collection: Registers of C.trachomatis tests from each of the three laboratories serving Stockholm 
County was used to assess all tests performed at the YHCs in Stockholm over a three year period 
(2010-2012). Each of the laboratories sent files containing personal identification numbers (PIN), date 
of test/tests, and test results to the Public Authority of Statistics Sweden (SCB), where socio-
demographic variables were added, and PIN were replaced by a unique identification number. The 
data files were then merged into one. Due to reason of secrecy for medical records between the 
different YHCs and the different laboratories, a joint medical record for youth attending, and testing 
at different YHCs was not available without the above described process. Final data from the 
laboratories and the SCB was received by the research team during autumn 2015. 
Data analysis: Descriptive analyses was used to report social-demographic characteristics of the 
cohort. The first test performed in one individual was considered the baseline test and marked the 
entrance of the study participant. Survival analysis was used to assess time to event (time to repeat test) 
and account for the different follow-up time for each individual in the study.  
 
3.3.2 Study II 
Study design and population: Qualitative interview study. We aimed to gain a deeper understanding 
of the individuals who repeatedly come for C.trachomatis testing in the YHCs, their motives for testing 
and how testing might affect their subsequent sexual risk-taking. Those who had tested for C.trachomatis 
at least twice during the previous six months were invited to participate in the study. In total we 
included 15 persons from eight different YHCs in Stockholm County. Participants were selected 
purposefully using heterogeneous sampling155 so that youth from different socio-economic areas were 
represented. Each participant was offered two movie tickets for time spent in the interviews.  
Data collection: A semi-structured interview guide with open ended questions was used to collect 
data. The interviews were conducted in Swedish, recorded and transcribed verbatim in Swedish. All 
interviews were performed by the same person. The interview guide is available as Appendix I. 
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Data analysis: The data was analyzed using a constructivist grounded theory approach.156 The 
interview transcript was red through, after that a line-by-line coding of the data was done. Categories 
emerged from the data as a result of constantly comparing of codes from different interviews, and by 
reasoning and consensus between two researchers. The categories were linked together creating a 
theoretical model explaining motives behind repeat testing. Memo writing, i.e. writing down analytic 
notes throughout the research process, facilitated the analysis of the data and the codes, and ultimately 
drafting the paper. 
 
3.3.3 Study III 
Study design and population: Qualitative interview study.  Designed to gain further understanding 
of the youth utilization of the testing services at the YHCs, sexual risk-taking among youth and primary 
prevention strategies. In depth interviews with 12 health care providers at 10 different YHCs, situated 
in different socio-economic areas of Stockholm County, were performed.  Participants were selected 
purposefully using heterogeneous sampling155 so that health care providers with different time 
experience from working at the YHC were represented. 
Data collection: A semi-structured interview guide with open ended questions was used in data 
collection. The interviews were conducted in Swedish, recorded and transcribed verbatim in Swedish. 
All interviews were performed by the same person. The interview guide is available as Appendix II. 
Data analysis: The data was analyzed using content analysis.157 158 Transcripts were read through on 
several occasion, and a line-by-line extraction of meaning unit was done. The sentences were shortened 
into condensed meaning units. Coding was done, each meaning unit was labelled with a code. Codes 
from the different interviews were then compared. Categories emerged from the coded data as a result 
of parallel analysis and mutual in-depth discussions between researchers. Three different overlapping 
themes were identified. 
 
3.3.4 Study IV  
Study design and population: Study IV was a pragmatic RCT designed to evaluate the effect of a 
smart phone app to promote sexual health and specifically condom use among youth in Stockholm 
County. Individuals who visited any of the 8/33 participating YHCs were screened for eligibility. The 
participating YHCs were situated in different socio-economic areas of Stockholm. Each participant 
was compensated two movie tickets for participation. 
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The Study Protocol is presented in a separate publication159 Our aim was to recruit participants both 
from the YHCs as well as through social media (advertising via Snapchat, Instagram, Facebook with 
redirection to the trial website for inclusion), however at the time for inclusion there were no prevailing 
guidelines or possibilities to create an account in social media originating from Karolinska Institutet.  
Inclusion criteria: Age 18 to 23, smart phone ownership, >2 sexual partners in the last 6 months, 
and residential registration in Stockholm County. 
Exclusion criteria: Unwillingness to participate, and women who exclusively have sex with women.  
Randomization: Eligible participants were individually randomized in a 1:1 allocation ratio to one of 
two arms. 433 youth who fulfilled the inclusion criteria were included in the study, intervention arm 
(n=214) or control arm (n=219). Stratified (for sex) block, randomization was used.  
Main outcome measures: The main outcome was self-reported condom use at the end of the study 
period. Secondary outcome measures were number of partners, occurrence of STI, pregnancies, and 
self-initiated STI tests.  
Intervention: Smart phone app called “Skyddsaget” plus standard of care was compared to the standard 
of care. The development of the intervention is described in a separate paper (Appendix III).160 
Standard of care: Standard of care was the normal routine at the YHCs which includes easy and 
prompt access to the clinics, exploring sexual behavior of the individual, giving recommendations and 
prescription of contraceptives, information about and distribution of condoms, testing for STI upon 
request from the youth and/or upon recommendation from the health care provider. 
Data collection and follow up: All data collection and follow up data collection was collected thru 
the app. The control group received a dummy app were only follow up questionnaires were available. 
Data submitted via the app by the participant was electronically routed onto a database that was stored 
on a secure server. To secure the data transfer from the app, all data was encrypted by using a Secure 
Sockets Layer (SSL). Baseline- and follow-up questionnaires are available as Appendix IV. 
Data analysis: Analysis was by intention-to-treat (ITT).161 The primary approach used to handle 
missing data was “last observation carried forward” (LOCF). Analyses were adjusted for sex, condom 
proportion at baseline, relationship status at baseline, and previous experience of STI as these variables 
were expected to influence condom use. STATA v16 software was used for all analyses.  
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4. ETHICAL ASPECTS 
 
Ethical approvals were for the four studies were obtained from the regional ethical board in Stockholm: 
2013/1399-31; 2015/739-32; 2017/651-31/4; 2017/8080-32. 
 
Given the sensitive subject of sexual health and behavior there were many ethical considerations in 
this project. Protecting the privacy of the patient is crucial at the YHCs and accordingly the recruitment 
procedures taking place at the YHCs was done with the objective to preserve this privacy.  
 
For the interview study (Study II) and the RCT (Study IV) youth were recruited upon visiting the clinic. 
There was a possibility that the participant approached, could have perceived themselves in a position 
of dependence in relation to the health care providers at YHCs, and accepted to enter the study without 
a genuine wish to do so. However, the health care providers involved in the inclusions at the YHCs 
informed possible participants about the present study, allowing time for reflection, and emphasizing 
the right to decline participation. They were also given written information about the study.  
 
The participants were informed, (prior to the signed the informed consent), that the questions during 
the interview and in the trial questionnaires would include intimate questions about sexual health and 
sexual habits. Written informed consent from each participant in the interview and the intervention 
study was obtained before the respective study was started.  
 
Exploring people’s sexual habits and condom use is an invasion of privacy and put additional demands 
on data privacy protection. The Swedish Personal Data Act, 1998:204 was followed throughout the 
trials.162 Only members of the research team had access to data collected in the project. Data files are 
stored on secure servers accessible only on pass worded computers used solely by the researchers.  
 
For the interview study with health care providers (Study III), written informed consent was obtained. 
The aspects of the researcher also being a colleague with the interviewees is discussed later in this 
thesis.  
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5. RESULTS  
 
Overall results: among youth attending the YHCs, a significant proportion repeated testing for 
C.trachomatis. Easy access to the clinics and the testing services were highly appreciated by youth, 
however the test and the test result itself did not affect subsequent sexual risk taking at individual level. 
Health care providers’ also expressed appreciation towards easy access to testing services, as it enabled 
individual sexual health counselling. In an attempt to complement and strengthen primary prevention 
strategies by a mHealth intervention, a youth friendly smart phone app was not found efficient. In the 
following section a summary of results from the different studies are presented separately. The results 
and its implications are further presented and discussed under in the discussion section.  
 
5.1 STUDY I: WHO ARE USING THE TESTING SERVICES AND WHAT IS THE 
INCIDENCE OF REPEAT TESTING 
 
All data originated from the YHCs in Stockholm County. In total, 65 951 (71.6% females) participants 
were included and 119 699 tests during 2010-2012 were analyzed. We found 42% repeat testers (≥ 2 
tests) in the data. Among all testers, 24.7% re-tested within 6 months of the previous test, among 
repeat testers 58.9% performed the next test within 6 months. The median number of repeat tests 
were 3 (range 2-18). At baseline, 8.2% of all individuals tested positive. The overall positivity rate 
declined marginally by number of tests performed, 8.0% were positive at second test, and 7.9% were 
positive at third test. Repeat infection was found among 925/27 680 (3.3%) re-testing youth. 
 
Of all re-testers, 80.3% were female (n=22213/27680). Men had higher rates of C.trachomatis positivity 
at baseline, both among single testers (9.8% for men vs 4.3% for women), and among repeat testers 
(17.1% for men vs 9.4% for women). Figure 9 shows the total number of tests and positivity rates 
among men and women separately. The incidence of repeat testing was 20.4/100 person-years for 
men, and for women the corresponding figure was 40.7. Repeat testing was associated with female sex 
and baseline positivity. Time to the second test was associated with the same variables. Women positive 
at baseline re-tested after 167 days (median) compared to men positive at baseline who retested after 
182 days (median). Most repeat testers (70.8%) did not change clinic between tests. 
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Figure 9. Total number of tests and overall positivity rate per sex 
 
 
5.2 STUDY II: WHY ARE YOUTH TESTING REPEATEDLY AND HOW IS RISK-
TAKING AFFECTED BY THE MEETING AT THE YHC AND THE TEST RESULT 
  
Fifteen (eight women and seven men) repeat testers were interviewed about their motives for testing, 
and how testing effected their subsequent sexual risk-taking. Testing was found to be a cyclic process 
driven by different aspects such as fear of infection a peer, the health care accessibility, and the idea of 
repeated testing as a preventive measure replacing condom use. Even though C.trachomatis was not 
perceived a serious infection, testing was described essential to reduce the risk of social consequences 
of infecting a peer. In all interviews, social stigma in infecting a peer stood out as a major reason for 
frequent testing. 
 
“The reason why youth test a lot is, you really do not want to be the one infecting someone else. I think that’s why you go 
there to test …infecting someone is embarrassing, I wouldn’t want to do that.” (21 year old woman)  
 
Hence, anxiety created due to possible social consequences was restrained by testing; youth tested to 
make sure they would not infect anyone and consequently bad rumors could be avoided. Furthermore, 
honesty towards a sexual partner was highly valued, i.e. being able to truthfully reveal STI status was 
considered important.   
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It was a prevalent opinion that good accessibility and free testing could lead to careless behavior and 
overuse of the services. The tests result (positive or negative) was not found to affect the retesting 
process, or the subsequent sexual risk taking, at least not towards more protective measures. A negative 
test result proved that unsafe sex was not that risky. 
 
Youth also expressed that health care providers preferably should not ask questions about the reasons 
for testing or questions about the youth sexual life. Such questions were considered personal and 
private.  
 
5.3 STUDY III: FINDING A BALANCE BETWEEN PRIMARY AND SECONDARY 
PREVENTION 
  
In Study III, health care providers were interviewed to explore the YHCs testing services from a 
broader perspective. Three overlapping themes were identified in the data: 
 
“Re-testing without having the talk is not meaningful” 
“Understanding reasons behind risky sexual behavior is essential for preventive work” 
“Having the talk: reaching out to promote condom use – challenges and opportunities” 
 
Health care providers were aware that numerous youth test repeatedly, and that testing by some, is 
perceived equally protective as using a condom. However, the repeat encounters with youth in relation 
to testing were perceived as positive for various reasons, including to reassure a disease-free status or 
to treat an infection which interrupts the chain of infection. More so, health care providers saw repeat 
testing/encounters as their chance to interact and eventually reach all the way with primary prevention 
strategies such as information on condom use and ways to healthy sexual behavior. Nevertheless, 
without time for reflection it was considered, that testing was meaningless. Additionally, health care 
providers highlighted concerns regarding not reaching young men to the same extent as young women. 
 
Health care providers recognized that C.trachomatis was not considered a serious infection. Thus using 
protection (condom) in relation to fear of medical sequelae was not a likely scenario. It was further 
emphasized that repeat testing might origin from a deep concern regarding other issues, such as 
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reimbursement for sex, general anxiety, or sexual abuse, and that testing was the youth way of reaching 
out.  
 
The concepts of self-reflection, self-respect, and self-compassion in relation to sexual health was 
emphasized in the third study but did not emerge in Study II. Health care professionals used these 
conceptions to reach youth with sexual health promotion.  
 
 5.4 STUDY IV: MHEALTH AS A COMPLEMENT TO PREVENTION WORK  
 
                              
Figure 10. Screenshots from the mHealth intervention “Skyddslaget”            
 
In a RCT we compared standard of care at the YHCs to standard of care plus the mHealth intervention 
(Figure 10), hence, the intervention was evaluated as a complement to routine prevention work carried 
out at the YHCs.  
 
In total, 972 young YHCs visitors were screened for eligibility and 44.5% fulfilled inclusion criteria 
and accepted participation. Exclusion was most commonly due to not having had ≥2 partners during 
the past 6 months, followed by unwillingness to participate. Recruitment was done over a 6 month 
period. The duration of the intervention was six months.  
 
Among the 433 participants, 67.4% were women, 96.3% were working or studying, 74.8% were living 
with their parents, and 89.1% were not in a steady relationship. Mean age for the first intercourse was 
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15.8 years, and the mean number of lifetime sexual partners were 15.8. The mean proportion of 
protected sexual intercourse at baseline was 31.5%, concurrent sexual relationships were reported by 
70%, and 40.9% had previous experience of STI. More than half (51.5%) said they were always, or 
almost always intoxicated, by alcohol or drugs while having sex with a new or temporary partner. 
Almost one of four (23.3%) stated that they had sex with someone during the past six months, that 
they did not wish to have sex with.  
 
In the intervention group, the proportion of fully protected intercourses (100% condom use) increased 
8.9% to 15.0%. The corresponding numbers for the control group were to 11.4% to 16.0%. There 
were no significant differences between the intervention and the control group regarding primary and 
secondary outcomes. Therefore, evidence from our internet based randomized trial did not suggest 
that an interactive mobile phone based app could result in significantly increased condom use among 
the youth. 
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6. DISCUSSION 
 
Main results in summary: Our first study showed that a significant proportion of youth attended the 
YHC repeatedly for C.trachomatis testing. As this was a retrospective cohort, the reasons for re-testing 
could not be elicited. However in a separate qualitative study, repeat testers indicated that testing was 
perceived as equally protective as using a condom, thus was used as means of prevention to avoid 
medical consequences, but foremost social consequences of infecting peers. Health care professionals 
saw ‘repeat testing as a means of prevention’ as a positive strategy for the youth to compensate for 
unsafe sexual practices, but only if the testing episode involved discussions around safe sexual practices 
and sexual health. In line with increasing number of efforts to affect sexual health we sought to study 
a mHealth intervention. We developed, implemented, and evaluated a smart phone app to promote 
sexual health. However, the intervention did not show an effect on the frequency of condom use 
among a group of sexually risk-taking youth. In the following sections, the main results/findings, 
methodology and broader implications from each study will be discussed.  
 
6.1 STUDY I 
 
6.1.1 Results discussion Study I 
We concluded that the incidence of repeat testing, (35/100 person years), for C.trachomatis among youth 
seeking care at the YHCs in Stockholm County is relatively high compared to numbers reported 
elsewhere.73 95 
 
We reached more females than males for STI testing (28% men) at the YHCs, most probably due to 
young women who can easily visit YHCs for other needs such as contraceptives. In Figure 9 (results 
section) we show that among > 90 000 female tests we found 6.8% positive cases, and among < 30 000 
men 11.6%. It might be suggested that increasing the testing rate among men and a more strategic 
testing among women would be more appropriate. However, there is no cut off level at what amount 
of testing we wish to find a certain level of cases. It can also be argued that more frequent male-testing 
and re-testing, and keeping accessibility unchanged for young females would be most beneficial. Each 
encounter with the health care system offers opportunities for health promotion practices and 
accessibility should therefore be preserved. Young men outside the testing services and not in our 
study population, have a risk not being reached by sexual health related interventions. 
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When analyzing tests in order of testing episode (first, second, third), we found that the overall 
positivity level were approximately 8% at all tests regardless of order. This could indicate that the 
repeat testers constitute a risk-group and risk-reductive measures do not increase by number of 
tests/number of encounters with health care providers. Among repeat testers, 3.3% had more than 
one infections during the study period, i.e. were re-infected. This is lower than previously reported 
elsewhere.163 164 One reason for promoting re-testing is to find people who are re-infected, either by a 
new sexual encounter or by an untreated partner. However, in our study, the level of re-infection was 
not high, and thus most infections among testers were attributed to persons who was previously 
uninfected. This suggests that the testing services are repeatedly being used by a number of sexually 
risk-taking youth who either haphazardly get the infection or they are `lucky´ enough to not be 
infected.  
 
6.1.2 Broader implications of the results of Study I 
We interpreted repeat testing as being “common” (42% re-tested ≥1 during the study period). 
However, in a study among STI-clinic visitors in Stockholm County, authors stated that “only” 43% 
of C.trachomatis testers had been tested in the previous 12 months, suggesting re-testing was not 
common.29 Irrespective of interpreting repeat testing as common or not, it is interesting to evaluate 
the opportunistic screening approach from utilization perspective. Who do we test, how often, and 
why? Repeat testing after an infection, or annual screening are not routinely recommended in Sweden.  
 
Each year all laboratories in Sweden are asked to report levels of C.trachomatis tests to the Public Health 
Authority. Some laboratories fail to report testing levels. Of those that does, most (70-80%) report 
number of tested persons,20 and other report number of tests. Yet some laboratories report both 
number of tested persons plus number of tests. Consequently, there are no accurate national data 
available of the amount of persons tested within the opportunistic screening program, nor the number 
of tests performed. With repeat testing levels of around 40%, the number of tested persons in one year 
might be lower than presented if the number of tests are reported. On the other hand, the number of 
tests performed are higher than presented if reported levels only refers to tested persons. Population 
coverage at a certain level, i.e. the number of persons tested has been suggested as an important aspect 
of C.trachomatis prevention.14 Consequently, without knowing the true coverage it is difficult to argue 
benefits and disadvantages of opportunistic screening.  
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6.1. Methodological discussion Study I 
To establish the level of repeat testing at the YHCs, which to our knowledge has not been reported 
before, we approached the operating laboratories in Stockholm County for data collection. Data was 
collected from the laboratories and SCB during 2013. However, when we completed the analysis and 
final draft for the manuscript for Study I, it was discovered that the numbers sent from the laboratories 
were not accurate. Data from 1/33 YHC was missing completely, data for a whole year was missing 
from 3/33 YHCs, and positive test results were missing from 4/33 different clinics. This resulted in 
re-opening of discussions with SCB, and a complete remake of dataset. The validity of the new data 
was assured by data-comparisons with the official number of reported cases in the County (2010-2012).  
 
Although only 40% of all positive tests that are reported in Stockholm County origins from the YHCs, 
we choose this as our setting. The remaining positive tests originate from, STI clinics, online sources, 
and various primary health care centers. The YHCs have a clear defined responsibility for primary 
prevention strategies among youth. On-line testing does not include personal contact with health care 
providers, and STI-clinics offering testing are aimed at older visitors. By restricting the study to the 
YHCs we most likely underestimated the level of repeat testing as a proportion of youth also use these 
other services. 
 
The studied period was 3 years. We do not know testing history before the studied time period, nor 
after, which is a limitation of the study. Ideally a longer time span could possibly have resulted in more 
accurate calculations regarding repeat testing, though a longer study would also be hampered by the 
same lack of testing history outside such a study period. 
 
In the present study, conducted to explore testing habits, a repeat tester was defined as someone who 
attended the clinics for a test more than once during the study period. This definition was pragmatically 
chosen to enable comparison to other international studies from the UK and New Zealand, reporting 
incidence of repeat testing and timing between tests.73 95  While testing >2 times during a 3-year period 
might not seem much, this can still have implications for evaluating effectiveness of the testing services. 
To fully understand youth health seeking behavior and sexual health in relation to testing for STIs, it 
would have been ideal to link the laboratory data to medical/clinical records to look for motives behind 
testing and sexual risk-taking factors. However, no such link exists and reviewing almost 120 000 
medical records manually was not feasible.  
36 
 
6.2 STUDY II 
 
6.2.1 Findings discussion Study II  
In our analysis a cyclic process related to C.trachomatis testing emerged. A positive test result and the 
consequent treatment was described as a “quick fix”. The accessibility to testing services, the perceived 
non-severity of the infection, and the “quick-fix” notion came to affect the subsequent decision/self-
negotiation to engage in unsafe sex. In this perspective, accessibility to testing services increases sexual 
risk-taking. Testing as means of prevention due to extensive accessibility could be described as an 
unintended side-effect of a well implemented screening approach.  
 
Youth in our study, were being cautious in relation to sex in the sense that society (health care system) 
tells them to be, namely test after risky behavior. It became clear that there was no stigma related to 
this behavior, quite the contrary, it was perceived as a ‘decent and appropriate’ thing to do. While it 
can be argued that testing is more costly than condom use, and therefore wasteful of health care 
resources, it is indeed a way of reassuring a disease free status and prevent transmission. By 
understanding the processes of unsafe sex, testing as means of prevention, “quick-fix”, and stigma 
related to infecting others, health care providers can adjust counselling.  
 
6.2.2 Broader implications from Study II 
Positively, scaling up STI prevention programs are currently being implemented around the globe. An 
increasing number of reports suggests that rates of re-testing/repeat testing are too low and therefore 
need to be improved and focused to specific risk-groups.165 166 167 101 Even though it is not official policy 
in Sweden, repeat testing is frequent among youth. Findings from our study adds an important aspect 
regarding prevention strategies for C.trachomatis and other STIs. It implies widespread testing and 
availability according to the Swedish model might increase sexual risk-taking and non-condom use. We 
cannot conclude that accessibility is contra productive, however we describe a possible “side-effect” 
of screening which should be taken into account when scaling up prevention strategies. Testing and 
treatment will have implications for the individual at the time of infection, but does not necessarily 
affect behavior in the long-term perspective.  
 
Youth interviewed in the present study reported no fear of becoming infected by C.trachomatis. 
Additionally, HIV was not perceived as a real treat in this group, which by large could be an adequate 
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assumption. Nevertheless, increasing reports on antibiotic-resistance in gonorrhea bacteria168 169 might 
enhance population positivity towards primary prevention for STIs (discussed below).  
 
6.2.3 Methodological discussion Study II 
In this study, we defined repeat testing as >2 tests per 6 months (corresponding to approximately 
16 300 youth in Study I). This definition was chosen by the research team as a realistic time interval to 
capture youth who routinely/repeatedly test for C.trachomatis. It is possible that some interviewed in 
this study was also part of the previous dataset. However, the participants were recruited from different 
YHCs and upon new visits, not from the original dataset.  
 
Reasons behind repetitive STI testing behavior and its effect on subsequent sexual risk-taking has not 
been widely studied. This led us to choose a grounded theory approach as it allows finding relationships 
between categories and possible development of new theories. A classical grounded theory as described 
by Glaser and Strauss,170 differs from the constructivist grounded theory as described by Charmaz that 
was used in this study.156 Constructivist grounded theory implies that findings are being constructed 
during the interaction between the researcher and the informants as opposite to being objectively 
discovered.156 171 The classical grounded theory believes in one reality on a phenomenon of interest just 
waiting to be found and the constructivist approach acknowledge that reality is being constructed 
during the interaction and that there is more than one perspective of reality.171 Furthermore, in the 
constructivist grounded theory, the personal experience and knowledge of the researcher is considered 
an asset while interpreting the data. Accordingly, in our study, the researchers’ pre-knowledge in the 
area being researched was the main reason for choosing the constructivist grounded theory approach.  
 
Saturation is a widely used term in qualitative research describing a situation when purposive sampling 
can be stopped. In recent years there has been some debate regarding the definition of the term and 
to what part of the qualitative work saturation refers.172 It has been described as when a category is 
full, i.e. no additional data emerge and properties of the category can be determined. Saturation can 
also be defined based on the coding of the data, i.e. when no more new codes are found. Additionally, 
saturation has been described as something that occurs in the interview situation.172 We defined 
saturation as no more new emerging codes. Data appeared saturated after approximately 12 interviews, 
however we conducted three more interviews to assure saturation.  
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Within the interview guide (Appendix I), a vignette describing a typical repeat tester was used. The 
purpose of the vignette was to use a hypothetical person to approach a sensitive topic.173 However 
youth spoke freely about the subject and thus this technique was only used in one third of the 
interviews. Trustworthiness in this study was assured by participants being presented with a summary 
of their responses in the end of the interview session as they were asked to confirm or contradict the 
information presented to them.  
 
6.3 STUDY III 
 
6.3.1 Findings discussion Study III 
In the interviews with the health care provider’s we identified three overlapping themes in their 
perception of repeat testing for C.trachomatis, sexual risk-taking, and primary prevention strategies. The 
phenomenon of repeat testing as means of prevention was acknowledged, however it was not 
necessarily perceived as problematic by all participants. Testing and attending the clinic repeatedly were 
looked upon as an opportunity for primary prevention including behavioral change interventions by 
counselling. In that context limiting access to testing services or restricting accessibility should not be 
considered. However it was stressed that “finding a balance” between primary and secondary 
prevention is desired, namely by time to meet the needs of the youth, time to problematize, and time 
to create alliances, as well as time for in-depth and risk-reductive communication. More than focusing 
on number of partners and number of unprotected intercourses, health care providers discussed 
implying self-respect and self-compassion to support youth in taking care of themselves.  
 
Furthermore, participants highlighted the need to recognize that “we are working with the adolescent 
brain”. Neuroscience research has shown that the brain is not fully developed until the age of 25, and 
accordingly optimal decision making might be limited up until that age.174 The need to incorporate this 
knowledge in respect to sexual health issues has recently been recognized,175 176 and should be 
considered when aiming to improve sexual health among youth.  
 
6.3.2 Broader implications of Study III 
In line with findings from our study where health care providers gave emphasis to primary prevention 
strategies as long-term work, interventions over time were found superior to single session 
interventions.177 With current demands of productivity, accessibility, and promptitude, both from 
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youth and the health care system, the obvious “quick-fix” solution of testing and treating, is perhaps 
the most tempting way to go even though findings from this project suggests no long term sustainable 
effect of focusing on secondary prevention. 
 
Only half of youth in a population based study in Sweden, reported to have had a preventive discussion 
in relation to their last STI testing.34 Reasons behind this was not described, however it could perhaps 
be attributed to time constrains. Together, these finding has implications for the health care system, 
i.e. finding a balance between productivity and quality. Short meetings at drop-in hours seems highly 
appreciated by the youth, but not by health care providers who demands sufficient time for reflection.  
  
Preventive strategies tend to be weighted in favor of secondary prevention, which is indeed 
advantageous to the youth as it provides them access to test and stay infection free. Promoting 
secondary prevention strategies might also be easier to report and evaluate compared to detecting 
behavioral change in relation to sexual health. Nevertheless, we should constantly be aware of the 
balance between primary and secondary prevention and how it corresponds to the goals of national 
C.trachomatis prevention.  
 
6.3.3 Methodological discussion Study III 
Data was analyzed using a content analysis approach as described by Graneheim and Lundman.157 158 
Compared to the grounded theory approach, content analysis does not aim to find a relationship 
between categories and develop new theories, but rather identifying, extracting and describing 
categories within the data. In this study we did not aim to find a new theory describing a phenomenon, 
but to triangulate findings from the previous study and additionally to describe health care providers 
view on sexual risk-taking and prevention strategies. Therefore, a content analysis approach was more 
found more appropriate than a grounded theory approach.  
 
Trustworthiness of the data was assured by member check, i.e. validating emerging understanding of 
the data with the informants.178 Furthermore, consensus on the codes, categories and themes were 
established by two researchers with different background. Additionally, findings from Study III were 
triangulated with findings Study II. Possible pitfalls from previous exposure and familiarity of the 
researched settings were avoided by constant awareness of the relationship between the researcher and 
the subject as well as the informants.   
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6.3.4 Trustworthiness in Study II and III 
In qualitative research trustworthiness is made up by four different elements: credibility, transferability, 
confirmability and dependability. Credibility refers to the researchers’ confidence the truth of the 
findings. Credibility is increased if the researcher are familiar with the setting before data collection 
was started, which was the case in the current studies. I spent approximately 3 years working at the 
YHC before data collection begun. Pre-understanding of the researched area facilitated identification 
of content themes which improves credibility. Further credibility can also be achieved by triangulation 
of findings which was done and discussed above.  
 
Transferability, refers to how applicable the findings are to other contexts than the one studied. For this 
purpose it is important that the setting is described in detail so that the reader can evaluate whether 
the findings could be applicable in other similar settings. In both qualitative studies of this thesis the 
setting was carefully described in the methods section. In similarity to generalizability, transferability 
of the findings in the two qualitative studies would foremost apply to an urban, high income setting 
where accessibility to health care services has been a present for a long period of time.  
 
Confirmability, refers to the level of neutrality in the findings, i.e. are the findings based on the 
responders’ answers or the researchers’ interpretations. It was with pre-knowledge and some 
preconceived opinions of health care utilization in relation to testing, that I went in to this project. 
Over the years my feeling on repetitive testing has changed towards a more positive view. During the 
years I have come to appreciate the pragmatic way that youth are handling consequences of their 
actions. The health care system offers solutions and youth accepts these. There was of course a risk of 
misinterpretation of the data due to pre-knowledge. It was avoided by continuous reflection and 
feedback discussions with research team members. Furthermore, my pre-conceived opinions did not 
match the findings from the studies. This was foremost apparent in the health care providers’ interview 
study, where responders offered a multi-dimensional view on primary and secondary prevention 
strategies that differed from mine.  More so, each step of the analysis processes has been documented 
and the analysis process was done together by two researcher from a different backgrounds.  
 
Dependability, refers to the possibility for other researchers to repeat the study and would the findings 
then be consistent. Dependability was assured by describing the analysis process thoroughly in the 
methods sections. We triangulated the researchers’ interpretation of the data. Additionally, we 
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performed member checks, i.e. we validated the understanding of the data with the informants by 
asking interpretative questions related to the emerging themes.  
 
6.4 STUDY IV 
 
6.4.1 Results discussion Study IV 
In our RCT condom use and proportion of fully protected intercourses, did increase with 
approximately 5% in both groups. The low condom use in this group of youth is a finding in itself and 
should be highlighted, communicated and if possible tackled. Secondary outcomes did also indicate a 
continued sexual risk-taking as approximately 20% experienced an STI and 70% tested at least once 
during the 6 months period. 
 
We aimed to increase condom use but the intervention did not have any effect in the “intention to 
treat” analyze. We do not believe that this was because of a Type II error. Even a larger sample size 
should not have allowed us to detect an effect. We conceive that there was no effect of the intervention 
as this was confirmed in a number of additional analyzes as per protocol, best-case scenario and worst-
case scenario. By imputing values according to different methods we accounted for different possible 
scenarios (further described below). No statistical differences were detectible in any of the analyzes.  
 
While the documentation of the usage level of the intervention is not complete due to technical 
problems, it was still sufficient to indicate that youth interest in the app waned after approximately 3 
months. This could also be deduced from the need to remind youth to answer the later follow-up 
questionnaires. Among the intervention group, 17% (30/176) of those answering the first follow up 
questionnaire, needed log in information again. Difficulties with influencing how much participants 
use the intervention (dose) has previously been described in similar RCTs.179 In additional to lost to 
follow-up there was most likely also a non-usage attrition. Both these are closely linked to one another. 
High rates of loss to follow-up indicates a high proportion of non-usage of the intervention among 
those who stay in the study,180 which consequently could represent that the participants did not find 
the intervention/app engaging enough. 
 
Participants in the RCT did not actively seek the intervention, which could influence the number of 
lost to follow-up. Conditions perceived as problematic to the participant, for example heavy 
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drinking,179 weight problem,181or herpes,182 could affect the will to stay in the study. As presented in 
Study II, non-condom use is not perceived as a problem that needs to be fixed. More so, it is possible 
that the intervention could have been effective in increasing condom use if targeted to an even younger 
population, i.e. even before sexual debut. As reported in Study III there seem to be a fascination for 
condoms in younger years that is eventually lost. By targeting the younger population, condoms could 
conceived as a natural part of the sexual life.  
 
6.4.2 Broader implications of Study IV 
Based on reported mHealth interventions, we had hopes for the intervention to serve the set purpose. 
We focused on developing the intervention together with youth from the target group,160 and we 
anticipated youth to want to interact with the app (Appendix III). Still, perhaps youth feel no need to 
be further informed or influenced to use a condom. Additionally, approximately 70% had tested for 
STI at least once during the study period, and participants could have used testing instead of condom 
as described in Study II, and consequently feel sufficiently protected as a result of testing.  
 
mHealth interventions that reports increased condom use has targeted younger people than we did.183 
More so, effect was measured after three months,184 there are data implying that the effect of mHealth 
interventions decrease with time.135 We believe a mHealth intervention such as ours should still be 
considered in a resource constrained setting or settings where access to primary and secondary 
prevention are low. 
 
6.4.3 Methodological discussion Study IV 
In designing the study we used the PRECIS-2 tool (Pragmatic Explanatory Continuum Indicator 
Summary),185 to ensure applicability of the trial results to the group the intervention intended to target. 
The pragmatic design of the trial (explained in further detail below) aimed to investigate if the 
intervention has an effect under existing routines, as opposite to ideal conditions. 
 
The trial protocol was registered at International Standard Randomized Controlled Trials (“Mobile 
Phone for Sexual Health in Youth” ISRCTN13212899186). A protocol paper was published159 shortly 
after inclusion started. To assure transparency of all important aspects, it was reported in line with the 
CONSORT checklist (Consolidated Standards of Reporting Trials).187 188 
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Participants in Study IV (and Study II) were recruited at the YHCs. We recruited persons >18 years 
old. By only including youth who could sign the informed consent without consulting their parents, 
the privacy of youth were maintained. Including from schools might have given a more representative 
selection of youth in Sweden in general, we decided to exclusively recruit from the YHCs, as this was 
more logistically feasible for the research team. Eight different clinics recruited participants. 
Geographically the clinics represented different socio-economic areas ranging from high income areas 
to low income areas with a higher migrant population.  
 
We targeted youth with risky sexual behavior, defined as at least two sexual partners during the past 6 
months. Youth attending the YHCs represents a risk-group, i.e. they are usually sexually active as 
compared to youth in general (e.g. in school environment), thus recruiting from the YHCs seemed 
appropriate. By including those with >2 partners we minimized the number of participants currently 
in a stable relationship. We anticipated the risk of including those who were previously in a stable 
relationship and had moved on to the next stable relationship within the past six months. In total 10% 
stated they were in a stable relationship at baseline. Furthermore, our experience indicated that youth 
move in and out of relationships, therefore >2 partners during the previous six months would 
effectively excluded those in a long term relationship. By recruiting a risk-population, the results could 
become less generalizable, on the other hand only risk-taking youth will need to change behavior.  
 
Our primary outcome was self-reported condom use. In relation to STI prevention we considered 
condom use as the most important. Indeed, risk of contracting STI increases with number of partners, 
(which is why this was included as a secondary outcome), however, if a condom is used any infection 
risks associated with having numerous partners is decreased. We considered including laboratory test 
results as an outcome, but due to feasibility and financial constraints, our secondary outcomes were 
self-reported testing episodes and self-reported occurrence STI. Due to accessibility at the YHCs we 
considered that those in need of a test would go to a clinic, thus did not need test-kits sent by mail. 
Occurrence of pregnancy was included as secondary outcome although pregnancy was not targeted in 
the app. Nevertheless, pregnancy would probably be less susceptible to recall biases than number of 
partners/protected intercourses, and could therefore serve as an indicator of unprotected sexual 
intercourse. 
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Power calculations assumed a condom use level of 50%, supported by previous reports in population 
based studies in Sweden.42 49 However, as we recruited a high risk group, retrospect calculation reviled 
an overestimation of baseline condom use. 
 
Questionnaires were designed so we could calculate mean proportion of condom use in the two arms. 
At baseline the mean proportions was approximately 30%, it did increase in the intervention group 
over the first 3 months however it then reverted to the same level as at baseline. Our outcome is based 
on 100% condom use, i.e. using a condom every time during an intercourse. We argue that consistent 
condom use is important in the STI context. Only with 100% condom use the primary prevention 
target of zero risk of infection is met.  
 
Given the above a person with a steady partner who did not use a condom would have a zero percent 
condom use and would then be considered equally unsafe as someone having had 6 partners without 
condom. In the analysis we therefore adjusted for relationship status at baseline.  
 
Youth life is a time of rapid changes in terms of living arrangements, relationship status, and smart-
phone ownership. From literature reports high loss to follow-up rates are described in on-line trials 
and we anticipated that keeping participants in the trial could be a challenge. Eligible participants 
consented to researchers reminding them via text message (SMS) or e-mail if responses to 
questionnaires were not provided a few days after the expected date. Participants were contacted via 
the mode chosen on the day following the expected response day. Those who still failed to respond to 
the questionnaire were contacted again after two days, and again two days following the second 
reminder, i.e. three reminders where sent out during the week after the expected response date. 
Participants in the control group also received an app, a dummy app containing only the follow-up 
questionnaires. This was done to facilitate the transfer of the data to the database.  
 
In total 358/433 (82.6%) participants answered the first follow-up questionnaire. Among these 76 
(21.2%) responded without any reminder (equal in both groups), and 161 (45.0%) answered after the 
first reminder. There were similar proportions for the responses to the second follow-up questionnaire. 
Methods for keeping participants in on-line trial by sending reminders has been previously described.189 
179 In our study youth were given two movie tickets upon inclusion, no further inducements were 
offered. Financial inducements and shopping vouchers have been described to increase levels of 
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completed follow-up questionnaires. The higher the value of the voucher, the higher retention rate 
was reported.189  
 
6.4.4 Internet based trials and high rates of loss to follow-up.  
In a fully on-line RCTs the researcher’s never meet the participant. Recruitment, randomization and 
follow up is done via the internet.190 In a partly on-line RCT, like ours, either inclusion or follow-up is 
made in a traditional face-to-face manner.190 There are several advantages with an on-line based trial. 
Trial recruitment via the internet can be highly efficient. In an on-line-based RCT aiming at increasing 
sexual health, 2000 participant were recruited via Facebook in five months.189 Reaching potential 
participants at a low cost and, reaching groups that would be otherwise be unavailable for clinical 
recruitment are other advantages.190 It has been argued that on-line recruitment can increase the 
external validity, i.e. by facilitating inclusion of different groups in society.179 Additionally, participants 
has been reported to appreciate the anonymity of an on-line trial, especially for sensitive variables  such 
as hazardous alcohol drinking191 and sexual health.128  
 
Among disadvantages with on-line conducted RCTs, the perhaps greatest concern are the commonly 
and large, loss to follow-up. A systematic review reported, 47% lost to follow-up for fully on-line RCT, 
and 36% lost to follow-up for partly on-line RCT.190 Individual trials that were not included in the 
systematic review also reported similar high numbers of lost to follow-up. 189 192 193 Retention rates as 
low as 15% was reported in an on-line-based trial aiming to increase STI preventive behavior among 
men who have sex with men (MSM).194 There are however reports on low rates of lost to follow-up in 
on-line trial with retention rates of 80-90%.182 195 
 
The large number of loss to follow-up in on-line RCTs makes these trials more suitable for pragmatic 
RCTs rather than an explanatory RTCs. Explanatory RCTs evaluate the effectiveness of an 
intervention in a controlled setting,196 thus online based RTCs with large number of loss to follow-up 
will not be suitable for trials aiming to investigate the effect of an intervention in an optimal setting.  
On the other hand a pragmatic RCT is used to evaluate the effect of an intervention in a real world 
setting, under the same conditions as where it should be applied.196 An intervention on sexual behavior 
delivered via an app, will not appeal to everyone but only a group of the target population. Therefore, 
despite the large number of lost to follow-up, an on-line pragmatic trial was suitable. The total number 
of lost to follow-up in our trial was 29.6% (128/433).  
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6.4.5 Intention to treat and handling missing data 
To maintain the advantages of randomization, i.e. minimize the risk unforeseen biases and 
confounders, it is important to analyze participants as they were originally randomized. Additionally, 
to avoid attritions biases, all randomized participants should be analyzed as randomized i.e. on an 
“intention to treat” basis which is a commonly described and accepted approach.161 The “intention to 
treat” approach with a “missing at random” assumption was described in our study protocol and 
subsequently executed.159 Missing at random means that a missing observation has nothing to do with 
the missing values, but it is conditional of other observed variables (such as age or sex).197-199 More 
male participants were lost to follow-up. However, stratification by sex was done previous to the 
randomization. There were no differences between those lost to follow-up in the control as compared 
to the intervention arm. There were no significant differences between those who completed the study 
and those lost to follow-up with regard to key baseline characteristics.  
 
In our protocol we failed to state how missing data would be handled in terms of the details of the 
imputation process.159 Imputation of missing data ensures the “intention to treat” approach,161 we 
chose to impute according to “last observation carried forward”, which is widely used method 
(however, not without criticism).  An “intention to treat”  as opposed to a per protocol analysis will 
not overestimate the effect of the intervention.200 Additionally, we performed sensitivity analysis (best 
and worst case scenario) as well as per protocol analysis as recommended.161 By performing per 
protocol analysis, i.e. only including those who answered to the follow-up questionnaires, the effect of 
the intervention was expectedly increased in magnitude (though still non-significant statistically).  
 
6.4.6 Internal validity 
Everyone who performed a test at the YHCs during a three year period was included in the first study, 
why there is no risk of selection bias. The risk of selection bias in the RCT was foremost related to 
high levels of non-consenters. During recruitment disproportionally more men than women declined 
to participate due to lack of interest and time. Men included in the study reported a higher means of 
condom as compared to women. It is possible that risk-taking men to a larger extent declined 
participation and thus the difference in condom use between men and women is due to selection biases 
in men which might have affected calculated odds ratios. It is possible that the intervention could have 
been more suitable to a more risk-taking group of men than we included. However, both men and 
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women were considered risk-takers, consistent condom at baseline were 13% for men and 9% for 
women respectively. 
 
Self-reported condom use, the primary outcome, is hazardous in both report and recall bias. We tried 
to minimize the risk of report bias by not choosing a Likert scale outcome, but a numeric outcome, 
i.e. number of fully protected intercourses with partner(s) were divided by number of partners. A 
Linkert scale would possible provide more subjective estimates. In studies where sensitive issues such 
as sexual health are explored there is also a risk of participants reporting socially desirable answers. 
This could have resulted in reporting a higher level of condom use than the true level. A sign of social 
desirable answers/bias could be that both control and intervention group increased the reported level 
of condom use during the study period. Young men’s higher reported condom use compared to 
women could indicate the same. Nevertheless, with the low reported levels of condom use in this 
study, we do not believe the risk of socially desirable bias to have affected the study substantially.  
 
We used self-reported measurements for both primary and secondary outcomes. Participants were 
asked to report events from 3 to 6 months back. Number of protected intercourse and number of 
partners ranged from 0-10, occurrence of pregnancy and STI ranged from yes-no, and number of tests 
enabled in a range of 4 different response option including “I don´t remember”. While recall bias is 
most definitely present in the study outcomes, we anticipated that most youth remembered important 
events that defined the primary and secondary outcomes. The questions used had previously been 
validated,201 furthermore, they were piloted in the target group.  
 
6.5 OVERARCHING METHODOLOGICAL CONSIDERATIONS 
 
6.5.1 Generalizability and external validity 
The setting of this thesis is the YHCs, and as in all clinical based studies there is a limitation with 
generalizability to the population outside the study setting. Our studies were done in an urban capital 
city with easy access to multiple YHCs and STI-clinics which further diminish external national validity. 
Furthermore, among those visiting the YHCs we sought a risk-taking population, i.e. those testing >2 
per 6 months, and those with >2 sex partners during the past 6 months. Compared to population 
based studies among youth in Sweden,34 42 43 data from our study participants did indeed indicate that 
had we recruited a higher risk population (condom use 10% compared to 25-50%). However, it has 
48 
 
previously been described that a small group of the youth population account for a large amount of 
C.trachomatis infections in Sweden,37 and with the focus of this thesis being C.trachomatis testing and 
prevention, we sought to capture what is going on within this risk group. The results from the first 
study reflects results from a STI-clinic based study,29 which extrapolates the results to people using the 
STI testing services in general. Yet, because of the large sample size in the first study (65 951 persons, 
119 699 tests) including all who tested at the YHCs, we can still extrapolate the conclusions to a large 
segment of the youth population in Stockholm County. The proven non-effectiveness of the app in 
our RCT proves it is not useful in this risk-group, but it might well be so in other setting. 
 
Even though the study is clinical based in an urban area in a high income country, findings from this 
thesis can still be of interest for populations in other settings. It has previously been described that the 
Swedish model is a role model example of C.trachomatis prevention, hence our findings, some 30 years 
after implementing opportunistic screening could imply what is to come out of scaling up testing 
services which is currently being done in countries around the globe.  
 
6.6 WHAT DO THE RESULTS TELL US 
 
6.6.1 Testing is done repeatedly by a proportion of youth 
Opportunistic testing for C.trachomatis, supported by the infectious disease law and the health care 
law,63 151 is offered to the population upon health care visits or via on-line testing. Ultimately, the 
objectives of screening for C.trachomatis are to reduce the spread of infections and to prevent serious 
reproductive health consequences in the population, which can occur both if the infection is treated 
or left untreated.81 
 
There are several aspects that have to be considered before establishing the medical benefits, as well 
as the cost-effectiveness of opportunistic screening for C.trachomatis. One is: can screening affect the 
prevalence of C.trachomatis in the population? A cluster randomized controlled trial from Australia 
including youth participants, found no C.trachomatis prevalence differences between the intervention – 
intensified repeat testing - and the control group, during a three year period.25 Conclusion made from 
the study was that reduction of C.trachomatis prevalence might not be possible using an opportunistic 
screening approach. It has been suggested that a reduction in C.trachomatis prevalence is possible if 30% 
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of the targeted population is screened on a yearly basis.93 202 We showed that a number of youth uses 
the testing services repeatedly, thus the population coverage is most likely overestimated. 
 
Usage level of the testing services (who tests and how often) in Sweden seems to be unclear even to 
policy makers and stake holders. We suggests that it is utterly important to investigate this further, i.e. 
replicate Study I from this thesis on a national level and thereby ascertain how many tests are done in 
the country every year, and how many people we reach through opportunistic testing. Without this 
knowledge we argue that it is impossible to make correct assumptions regarding benefits or 
disadvantages related to screening for C.trachomatis. We do not know who or how many we reach, nor 
who we do not reach. Reporting cases per 100 000 inhabitants is indeed important as it enables 
comparisons between countries. Nevertheless, it would also be important to report levels of 
C.trachomatis based on tests performed and tested persons.  
  
Another aspect to consider while evaluating the opportunistic screening approach is: how many would 
suffer server sequelae if C.trachomatis is not treated? While approximately 20 % of PID diagnosis can 
be attributed to C.trachomatis,203 1-4% of untreated C.trachomatis lead to PID.10 75 It has been estimated 
that 45% of tubal infertility can be attributed to C.trachomatis infection,204 and that the probability of 
tubal factor infertility for women who had C.trachomatis  range from 1-4%.205 206 Today risk of severe 
consequences appears to be lower than previously reported. Furthermore, the effectiveness of 
screening on severe consequences depends on time for the infection to ascend to the upper genital 
tract and cause for example tubal damage, which is unknown.13 207 
 
This thesis did not aim to evaluate the cost-effectiveness of STI prevention. The total cost of STI 
prevention among youth in Stockholm and Sweden is difficult to measure. Primary and secondary 
prevention for sexual health include ongoing activities involving many actors such as schools, YHCs, 
parents, peers, and the regular health care system. However, cost-effectiveness analysis including 
quality adjusted life year calculations based on up-to-date assumptions of risk of sequelae should be 
attempted. In studies from Sweden cost-effectiveness were based on assumptions that 20-30% of 
untreated females would suffer from PID,77 208 and the risk of tubal infertility 4-6% .77 208 It might well 
be that the opportunistic screening approach of today is beneficial, concerning cost-effectiveness 
related to severe reproductive health complications. Until we have reliable data, we cannot conclude 
either. Furthermore, nowhere, including Sweden, is there a target, or a defined acceptable prevalence 
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level of C.trachomatis or health consequences thereof ,14 which makes it even harder to evaluate the 
effects of on-going activities.  
 
6.6.2 Testing can impair risk-reduction 
With extensive health care resources invested in prevention strategies, it is clear that the state and the 
authorities perceive C.trachomatis to be a serious infection. However, it appears youth are not of the 
same opinion. Findings from Study II and III imply that accessibility to testing even can have negative 
effects on sexual risk-taking. Youth are affected by the environment in where they live, i.e. YHCs, 
health care provided free of charge, and health care policies. Additionally, health beliefs such as 
C.trachomatis not being a severe infection and accessibility to health care services affects the sexual risk-
taking. Youth express simultaneous yet contradictory feelings regarding C.trachomatis. On one hand it 
can be worth not using a condom despite contracting an infection, i.e. nothing to fear in relation to 
unprotected sex. On the other hand STIs can be devastating in relation to rumors among peers and 
perceptions of “being fresh”. Testing repeatedly takes care of the fear of social stigma. In the interviews 
the outcome of the meeting with the health care service was referred to as easy and pleasant, thus no 
need for health behavior change was needed. Interestingly, health care providers did express a belief 
that in the long term they would be able to affect youth towards a more protective behavior, however 
this was not confirmed by youth.  
 
Access to testing services is further facilitated by increased number of on-line tests performed during 
the past decade (Figure 11).209 According to findings in Study III, testing without primary prevention 
strategies/talk is not meaningful and this knowledge contradicts scaling up on-line testing. 
Furthermore, the same confusion regarding tested persons/tests performed also applies for on-line 
tests in Stockholm County.209 Indeed, with on-line testing we could potentially reach more people at a 
lower cost (240 SEK including testing material, analysis, and sending the sample by mail 210) as the cost 
of health care providers is diminished. However, one must keep in mind that the health promotion 
initiative will be absent. There is a possibility of accessibility impairing risk-reduction among youth, 
and on-line testing could potentially increase this risk even further. Consequently, the discussion 
regarding the benefits of secondary prevention should include scaling up on-line testing services as 
well.  
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Figure 11. Number of on-line tests performed in Stockholm County (“Chlamydia on line”) 
2010-2018, divided by age group and sex.209 
 
6.6.3 Behavior change needed but are we facilitating it effectively?  
Among visitors at the YHCs, categorized as risk-taking youth, we found low condom use. Only 10% 
of youth were fully protected, which indicates a need for behavior change. As described throughout 
the thesis, “test and treat” is a feasible approach (and embraced by the youth) to decrease the risk of 
spreading the infection and minimize the risk of complications. However, it will not prevent infections 
per se. While it is positive that youth have adopted the test and treat approach, it is not optimal. 
Without making the best the enemy of the good, this approach is not conducive to safe sexual practice 
as routine among youth, which would be the ideal desired behavior as far as C.trachomatis control is 
concerned. Additionally, there are economic implications, the price of one condom ranges from 3-13 
SEK,211 which is much lower than the price of a test. More alarmingly, in the past years there have 
been a significant increase in gonorrhea (15% per year 2009-2015), foremost among MSM, but also 
via heterosexually transmitted infection among younger age groups.212  Given the emerging 
antimicrobial resistance for gonorrhoea,213and risk of STIs overall,  we argue that ultimately a change 
of behavior among youth i.e. increased condom use, is essential in a broader context.  
 
Motivation is fundamental to behavior change. An important issue to youth was the possible social 
stigma among their peers about being held ‘responsible’ for spreading the infection. This notion was 
one we tried to emphasize in our mHealth intervention -not increasing stigma, but appeal to, and 
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strengthen youth’s motives to act in a way that does not result in anxiety related to stigma. However, 
the mHealth intervention did not produce a significant improvement in condom use. We need to still 
explore and test interventions that will facilitate a sustainable change of behavior among youth towards 
adopting safer sexual practice (i.e. increased condom use) as a routine.   
 
 
  
53 
 
7. CONCLUSIONS 
 The testing services of the YHCs are repeatedly being used by a significant proportion of youth. 
 Testing is, by some repeat testers, perceived as equally protective as using a condom.  
 Secondary prevention - in its current form - is unlikely to affect sexual risk-taking towards 
safer sexual practices. 
 Spreading C.trachomatis among peers can have serious social consequences and testing 
after each unprotected intercourse will minimize this risk. 
 Finding a balance between testing and primary prevention strategies by having the time for 
reflection and problematizing of risky sexual behavior is essential for successful prevention of 
C.trachomatis and unsafe sexual practices. 
 Among sexual risk-taking youth visiting the YHCs, condom use is low, which indicates 
the need for primary preventions strategies to be strengthened.  
 The evaluated mHealth intervention, a smart phone app, developed to increase sexual 
health did not influence condom use among youth.  
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8. SUGGESTIONS FOR FUTURE RESEARCH 
 
To further explore the opportunistic screening services for C.trachomatis, Study I should be 
replicated on a national level, i.e. include all laboratories and County Councils in Sweden in a 
national survey to assess population coverage (number of persons tested) and number of tests 
performed in the country per year. 
 
Results from the national population coverage study can be included in cost-effectiveness analysis 
for opportunistic screening for C.trachomatis. In addition, such a study should be based on up-to-
date assumptions of the relationship between the infection and its possible consequences.  
 
Exploration with youth living outside the urban areas to investigate how accessibility to testing 
services affects sexual risk-taking and testing habits. Further exploration of health care provider's 
perception of prevention strategies in relation to testing services in other outside-urban settings. 
 
Qualitatively explore with participants from Study IV why the intervention was/was not found 
engaging.  
 
Further exploration of the possibility of using individually targeted mHealth intervention for at-
risk-population in this, and other settings.  
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9. SVENSK SAMMANFATTNING 
 
9.1 BAKGRUND  
Varje år smittas uppskattningsvis 350 miljoner människor i världen av en av fyra sexuellt 
överförbara infektioner (STI) (klamydia, gonorré, syfilis eller trichomonas). Klamydia är den 
vanligast rapporterade STI, både globalt och i Sverige. Ungdomar drabbas oftare än den äldre 
populationen. Klamydiainfektionen kan ge allvarliga komplikationer framförallt hos kvinnor, 
såsom infertilitet och kronisk smärta. För att förhindra spridning av STI krävs en rad samverkande 
åtgärder såsom sexualundervisning, kondomdistribution och tillgång till vård inklusive 
provtagning, behandling och smittspårning. I Sverige är sexualundervisning i skolan ett 
obligatoriskt moment och tillgången till vård är god. Sverige har en lång tradition av att 
tillhandahålla gratis klamydiaprovtagning. Redan 1982 erbjöds kvinnor som genomgick abort eller 
preventivmedelsrådgivning provtagning för klamydia. Även partners till smittade kvinnor 
kontaktades via smittspårning och fick lämna prov. Klamydia ingår sedan 1988 i Smittskyddslagen. 
Trots dessa förbyggande åtgärder så ökade antalet rapporterade fall av klamydia under de senaste 
två decennierna och har nu stabiliserats på en hög nivå. Nationella studier utförda i Sverige, 
rapporterar låg kondomanvändning bland ungdomar.  
  
9.2 ÖVERGIPANDE SYFTE  
Syftet med detta projekt var att studera provtagningsvanor för klamydia bland ungdomar som 
besökte ungdomsmottagningarna i Stockholm Län. Vi har fokuserat på hur provtagning och 
provtagningsresultatet påverkar sexuellt risktagande och därefter följande provtagningsepisoder. 
Vidare utvecklades en mobiltelefonibaserad intervention i syfte att förbättra sexuell hälsa och öka 
kondomanvändning bland ungdomar. Denna intervention har utvärderats i en randomiserad 
kontrollerad studie.  
  
9.3 RESULTAT 
9.3.1 Delstudie I 
Registerbaserad studie på laboratorieresultat. Under en treårsperiod utfördes 119 699 
klamydiaprover på 65 951 ungdomar på ungdomsmottagningarna i Stockholm Län. Totalt 7.9% 
av alla prov var positiva och 42 % av alla ungdomar upprepade provtagningen (mellan 2-18 
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provtagningar) under studietiden. Mer än två tredjedelar av studiedeltagarna var kvinnor. Bland de 
som upprepade provtagningen fann vi höga klamydiasiffror både vid den första och de följande 
provtagningarna. De kvinnor som testat positivt vid första provtagningstillfället återkom i större 
utsträckning och med kortare tidsintervall än övriga grupper. Kvinnor som testat negativt återkom 
i större utsträckning än män som testat positivt vid första provtagningstillfället.  
  
9.3.2 Delstudie II  
Kvalitativ intervjustudie som syftade till att utforska (1) vad som motiverar ungdomar att testa sig 
vid upprepade tillfällen samt (2) att förstå hur provtagningen påverkar sexuellt risktagandet. Vi 
fann att ungdomar inte upplever klamydia som en allvarlig sjukdom och att provtagning uppfattas 
som ett skydd som går att jämställa med att använda kondom. Varken provtagningen, 
provtagningsresultatet eller mötet med personalen på ungdomsmottagningen påverkade 
ungdomar att skydda sig mer. Upprepade negativa provtagningsresultat visade sig leda till ett ökat 
risktagande i relation till sex och kondomanvändning. Den största faran med klamydia beskrev 
ungdomar vara relaterat till att risken att smitta någon annan vilket kunde leda till ”dåligt rykte”. 
För att minimera risken att sprida smittan, uppfattades provtagningen som en god möjlighet att 
försäkra sig om att man är ”fräsch” och ”ren”.  
  
9.3.3 Delstudie III  
Kvalitativ intervjustudie med personal på ungdomsmottagningarna. Vi undersökte deras syn på 
provtagning, sexuell hälsa bland ungdomar samt preventivt arbete. Personal som intervjuades 
visade sig vara medvetna om att upprepad provtagning ibland användes istället för kondom. Dock 
uttryckte man att tillgänglighet till mottagningarna samt provtagning var en förutsättning för att 
kunna välkomna, möta och nå ungdomar i ett preventivt syfte. Vidare såg man det preventiva 
arbetet som en fortlöpande och ibland långvarig process som kräver tid och närvaro i varje möte. 
Flera uttryckte en frustration över de korta besök som erbjuds på drop-in mottagningarna. Att 
genom reflektion och samtal med ungdomar hitta en balans mellan sekundär prevention 
(provtagning och behandling) och primär prevention (främja kondomanvändning) ansågs viktigt.  
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9.3.4 Delstudie IV  
Randomiserad kontrollerad studie (RCT). Individuella intervjuer, samt fokusgrupper med 
ungdomar gav underlag för att utveckla en mobiltelefonibaserad intervention (applikation - app) 
med syfte att främja sexuell hälsa och att öka kondomanvändning. En app till en "smarttelefon" 
utvecklades och utvärderades i en randomiserade studie ("The MOSEXY trial" - MObile Phone 
intervention for SEXual health in Youth). En mobiltelefonibaserad intervention för sexuell hälsa 
har inte tidigare testats i Sverige. Vi inkluderade 433 ungdomar som under det förgående halvåret 
haft ≥ 2 olika sexpartners. Hälften av ungdomarna fick tillgång till appen och andra hälften fick 
inte tillgång. Både grupperna svarade på frågor vid 3 olika tillfällen. Vi fann låg kondomanvändning 
i båda grupper vid studiestarten. Endast 1 av 10 uppgav att de varit helt skyddade med kondom 
under det senaste halvåret. Då studien avslutades hade kondomanvändningen gått upp något i 
båda grupperna men det var ingen skillnad mellan gruppen som fått tillgång till interventionen och 
den grupp som endast haft tillgång till vanlig vård. Studietiden varade 6 månader, 20 % fick under 
denna tidsperiod en sexuellt överförbar infektion och 70 % lämnade prov för en sexuellt 
överförbar infektion.  
  
9.4 SLUTSATSER 
Bland ungdomar som besöker ungdomsmottagningarna för klamydiaprovtagning så förekom 
upprepad provtagning bland en stor andel ungdomar. Tillgängligheten till provtagning 
uppskattades av ungdomar, dock ledde inte provtagningen, resultatet eller kontakten med 
personalen på ungdomsmottagningen till en minskning av sexuellt riskbeteende. Personal på 
ungdomsmottagningen uttryckte att tillgängligheten är viktig och en förutsättning för preventivt 
arbete med ungdomar. Dock måste tid finnas för samtal och reflektion kring sexuell hälsa, annars 
riskerar tillgänglighet till provtagning att inte ha önskad effekt. Enkel och snabb tillgänglighet till 
provtagningsservice är en viktig komponent för att förhindra spridning av sexuellt överförbara 
infektioner. Det är dock viktigt att sekundära preventiva insatser så som provtagning, inte tar fokus 
från primära preventiva åtgärder som syftar till ökad kondomanvändning. 
  
I ett försök att stärka de preventiva åtgärderna med en smarttelefon-app fann vi att denna inte 
ökade kondomanvändningen bland ungdomar. Även om denna app inte hade någon effekt på 
kondomanvändningen, så finns potential för en sådan intervention att nå stora delar av 
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ungdomsgruppen/er. Utbrett sexuellt risktagande bland dessa ungdomar vittnar om ett stort 
behov av att stärka preventionsarbetet ytterligare. 
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APPENDIX I: INTERVIEW GUIDE STUDY II 
 
Aspects to explore Questions 
Introductory questions Tell me a little bit about yourself.  
Explore age, school, work, and family. 
Using the clinic Tell me about your experiences of visiting the clinic.  
What is the most common reason you come here?  
Testing for Chlamydia Vignette:  
20 year old Alice had had a positive Chlamydia test 
about 3 months ago. She was upset when she got the 
test result and her ambition was to change her risky 
sexual behaviour by using a condom and having fewer 
sexual partners. When she comes to the clinic again 
she has had 3 new partners in the last 3 months since 
her infection. She used a condom with the first partner 
but with the next two she had no protection.  
 
What do you think about that? 
How do you think that happens? 
Can you tell me about your experiences being tested 
for Chlamydia?  
What do you think about / know about Chlamydia? 
Sexual risk-taking What do you consider being a risky sexual behaviour?  
What do you consider having a safe sexual life is?  
Alcohol? 
Multiple partners? 
Emotional risk? 
Aspects influencing repeated testing Can you tell me a little bit more about being tested 
repeatedly for Chlamydia?  
What do you think influences young people to test 
repeatedly for Chlamydia? 
What happens when you get a test? 
What about condom use and repeated testing? 
What about other contraceptives and repeated testing? 
Trust in partner? What do you think about that? 
Does the fact that testing is free matter?  
Security for HIV 
Security for Chlamydia 
What would happen if people would start to pay for it?  
Security in repeated testing Tell me about how you feel when the test result is 
negative?  
How does the negative test result influence you? 
If you would test positive for Chlamydia how would 
that make you feel?  
Would a positive result influence you in any way?  
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APPENDIX II: INTERVIEW GUIDE STUDY III 
 
Aspects to explore Questions 
Introductory questions Tell me a little bit about yourself.  
Explore age, working experience. 
Working at the Clinic Tell me about your experiences of working the clinic.  
What do you appreciate with the Youth Health 
Clinic? 
What is difficult / challenging?  
Sexual risk-taking What do you consider being a risky sexual behaviour 
among youth?  
What do you consider having a safe sexual life is?  
Alcohol? Drug use? 
Multiple partners? 
Emotional aspects? 
Testing for Chlamydia  Vignette:  
20 year old Alice had had a positive Chlamydia test 
about 3 months ago. She was upset when she got the 
test result and her ambition was to change her risky 
sexual behaviour by using a condom and having 
fewer sexual partners. When she comes to the clinic 
again she has had 3 new partners in the last 3 months 
since her infection. She used a condom with the first 
partner but with the next two she had no protection.  
 
What do you think about that? 
How do you think that happens? 
What do you think influences young people to test 
repeatedly for Chlamydia? 
Are there any risky behaviour that influences that? 
How so? 
Aspects influencing repeated testing What about condom use and repeat testing? 
What about other contraceptives and repeat testing? 
Trust in partner? What do you think about that? 
Does the fact that testing is free matter?  
What would happen if people would start to pay for 
it? 
Youth perception of HIV risk 
Youth perception of STI risk 
Security in repeated testing Tell me about the reactions to a negative test result. 
According to you, how does the negative test result 
influence subsequent sexual behaviour? 
Tell me about the reactions to a positive test result. 
According to you, how does the positive test result 
influence subsequent sexual behaviour? 
Social stigma in contracting STI / Infecting someone 
else. Gender perspective. 
Primary prevention strategies How would you like to work with sexual health 
promotion? 
How can we / can we affect condom use among 
youth? 
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Introduction 
 
Mobile health (mHealth), using mobile devices to address health priorities, has shown to be effective 
in increasing sexual health among youth such as increased knowledge regarding sexual health, increased 
testing for Sexually Transmitted Infections (STI), and condom use [1,2]. Up to date, evaluations mostly 
refers to interventions delivered via computer, e-mail, and text messages [1,2]. The possibility to 
download applications (apps) on mobile devices has opened up opportunities to develop and distribute 
health promotion interventions [3]. Health promotion via apps is suitable for youth, a tech savvy 
population who spend a significant period of time on their mobile phones. Additionally, the coverage 
of mobile phone ownership is high, 98% of the whole Swedish population own a mobile phone and 
92% of these are smart phones [4]. In order to attract young users, and get youth to engage with an 
app on sexual health, it is important to involve youth in the development of the app [5].  
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Theoretical framework - the Trans-Theoretical Model and the Integrated Behavioral Model: 
In developing the smart phone app to increase sexual health and condom use among youth, we used 
two different models of behavioral change. The Trans-Theoretical Model (TTM), a model that 
conceptualizes the process of intentional behavior change and includes different stages of change [6]. 
These stages are: Precontemplation - not ready for a change; Contemplation - getting ready for a change; 
Preparation – intends to take action within foreseeable future and has taken some behavioral steps in 
this direction; Action – Changed behavior; Maintenance – adhere to the new behavior. The Integrated 
Behavioral Model (IBM) contains five components affecting behavior [7]: Behavioral intention 
(determined by attitudes, perceived norms, and personal agency); Knowledge and skills to carry out the 
behavior; Importance to the individual; Environmental constraints that make behavioral performance difficult; 
Habit (experience performing the behavior, the behavior will become habitual). 
Objectives 
The objectives of this study was to explore with youth and obtain their input on the content of a smart 
phone application to promote safe sex. The ideas from the youth were to be incorporated subsequently 
in an application to be tested in the context of the Youth Health Clinics in Stockholm County. 
Methods 
Setting: This study was conducted at the Youth Health Clinics (YHCs) in Stockholm County, Sweden 
(250 clinics in the whole country, 33 in Stockholm County) [8,9]. 
Participant selection: We conducted 15 individual in depth interviews with youth at the YHC, and 
two focus group discussions (FDGs). Interviewed participants were selected purposefully using 
heterogeneous sampling [10] so that youth from different socio-economic areas were represented. For 
the FGD, youth attending one YHC as clients, and were invited to participate.  
Data collection: Interviews with youth aged 18-22 were performed from April 2015 to April 2016 (7 
males, 8 females). The FGDs were held in October and November 2016. The first FGD had 4 female 
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participants, while the second included 3 females and 2 males. Interviews with youth were performed 
by the first author (AN) in Swedish. They were recorded and transcribed verbatim. The FGDs, 
supported by three members of the research team, were recorded, notes were taken, and a summary 
of notes and the recordings were made.   
Areas explored: The questions posed in the interviews and in the workshops were; Why do you think 
condom use is low among Swedish youth? What is positive with condom use? What do you think about mobile phones 
to reach young people with health messages? Could a smart phone app work to mediate safe sexual practices? What 
would such an app contain? How could the app be made attractive to youth? Mode and timing of push-notices 
(message/reminders to engage in activities) in the app? 
Data analysis: The recordings and transcripts were listened/read through on several occasions. 
Categories emerged from the data as a result of parallel analysis and mutual in-depth discussions 
between researchers.   
Ethical considerations: Written informed consent was obtained from each participant. The study 
was approved by the Stockholm Regional Ethical board (reference number 2013/1399-31/2, with 
amendment 2015/739-32). 
Results 
The smart phone app (subsequently named “Skyddslaget” or ‘Protection team’) was developed based on 
the categories that emerged from the data from interviews and FGD. These categories were embedded 
into the app content, mode, and tone while being guided by the TTM and IBM frameworks. 
Suggestions for the content, mode, and tone of the app are summarized in Table 1. With regard to 
content, youth requested sexual education, including STI information. Additionally condom specific 
information including practical usage technique, advises on how to have “the condom talk”, and 
decrease shame related to condom use were requested. Youth suggested different modes to deliver the 
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content including text messages, movie clips, and push-notices. The tone of the messages delivered, 
youth suggested, should be fun and entertaining and supportive (Table 1). 
Table 1: Requests from youth, regarding the content, mode, and tone of the app.  
Content  Mode Tone 
Information regarding STI 
 
Sexual education 
 
Condom-information  
 
Increase self-confidence 
related to condom use  
 
Condom technique 
  
Preparation for the condom 
talk 
 
Decrease shame and stigma 
related to condom use 
 
Alcohol and unsafe sex 
 
Questioning norms (sex 
with condom is not good) 
 
Normalizing condoms 
Games 
 
Week-end condom 
reminders 
 
Movie clip 
 
Imagery (emojis) 
 
Text (not heavy) 
 
Quiz 
 
Push-notices 
 
Adding new information to 
keep interest 
 
Interactive 
 
 
 
 
Fun and entertaining 
 
Supportive 
 
Containing pep-talk  
 
Allowing 
 
Scaring (the “light-version”) 
 
Identifying with peers 
 
Encouraging 
 
 
The inputs from Table 1 were sorted into different groupings that were each reflected in one of the 
nine focus areas of the application during the subsequent phase of app development. These were: 
Condom obstacles and solutions; Quiz; Games; Self-refection; Challenges; “Others tell” (peers tell their story, the doctor 
informs); Condom tip, Pep-talk and bosting; and Random facts. Thus, the focus areas emerged both from the 
content, mode, and tone requested.  
App material for the different focus areas was developed relative to the different stages of change in 
the TTM, where each stage lasted for 30 days, supporting youth to move from one stages to the next.  
Content was added into the app on a daily basis for 180 days, the time period for which the intervention 
lasted. The self-reflecting and pedagogic tasks in the app were based on the IBM. These tasks addressed 
feelings, thoughts, experiences, attitudes, and perceived self-control in relation to condom use and 
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unprotected sex, and were mainly found under the categories “Condom obstacles and solutions” and “Self-
reflection”.  
The informative part of the app (i.e. sexual education, information about STIs) was mainly presented 
under the focus-area “Others tell” (the doctor informs) and “Random facts “. Additionally “Random facts” also 
contained curiosities related to sex and sexuality. The app was therefore designed also to sustain the 
interest of the youth over a few months. The interactive actions under the other focus areas including 
Quiz, Games, and Challenges were also intended to sustain engagement. Identification with peers was 
strongly suggested by youth and was included in the “Others tell” (peers tell their story), this aimed to create 
a sense of identification and thereby eliminate possible feelings of shame related to a behavior. “Others 
tell”, contained information mediated by movies and sound-clips. The encouraging tone was notable 
throughout the intervention, and mainly found under the category “Pep-talk and boosting”. The aim was 
to support the target group in their behavior changing process. Each day of the intervention at least 
one condom tip was posted (under the category “Condom tip”).  The aim was to inform about different 
condom types and sizes, and normalizing condoms by daily exposure. Additionally push-notices were 
used to capture the attention of the youth that new content had been added into the app, and also each 
Friday evening, a condom reminder push-notice was sent out to participants. 
The team that developed the app had varied backgrounds including YHC staff working with youth 
(midwife), public health, medicine, information technology and behavioral science. The function and 
content of the app was initially piloted among ten users.  
Discussion 
We used the data from FGD and individual interviews with youth belonging to the target group to 
develop  the content, mode, and tone of a smart phone app to promote safe sex. Inputs from youth 
were embedded into existing frameworks previously proved successful (TTM and IBM) [11]. To use 
input from youth is important as the success of the intervention largely depends on the level of 
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engagement and usage by youth. mHealth interventions are particularly suitable for youth and sexual 
health promotion as the intervention is delivered in a familiar, and discrete way to at-risk population 
[12].  Analysis from the MOSEXY-Trial (MObile phone for SEXual health in youth) where the 
“Skyddslaget” app was subsequently evaluated in a pragmatic randomized controlled trial and will be 
reported separately [13].  
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APPENDIX IV: QUESTIONNAIRES STUDY IV 
Bakgrundsinformation frågeformulär vid inkludering som besvaras i applikationen  
Hej. Första frågeformuläret består av 27 frågor med olika svarsalternativ. Dina ärliga åsikter och svar är viktiga. Vi 
lägger inga moraliska värderingar i hur du svarar på frågorna. Din identitet är helt skyddad.  
 
1. Jag är   
o man  
o kvinna  
o vill ej definiera 
 
2. Hur gammal är du?  
o 18 
o 19 
o 20 
o 21 
o 22 
o 23 
 
3. Högsta avslutade/pågående utbildning?  
o Grundskolan  
o Gymnasiet 
o Högskola/Universitet 
 
4. Sysselsättning  
o studerar  
o arbetar  
o arbetssökande 
o arbetar och studerar 
 
5. Boendesituation  
o bor hemma med föräldrar/förälder 
o har flyttat hemifrån 
 
6. Vad stämmer bäst in på hur du lever just nu 
o Singel 
o Fast relation 
o Dejtar en person men har inte en fast relation 
o Dejtar två eller flera men har inte en fast relation 
o Har en återkommande sexpartner 
o Har flera återkommande sexpartners 
 
7. Har du under de senaste 6 månaderna haft en pågående sexuell relation med en person som under 
samma period haft sex med någon annan än dig? 
o Nej 
o Nej, jag tror inte det 
o Ja 
o Ja, det tror jag 
o Jag har ingen sexpartner 
 
 
8. Hur gammal var du när du hade samlag (vaginalt och/eller analt) första gången? 
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9. Med hur många partners totalt har du har du haft samlag (vaginal och/eller analt) i hela ditt liv? 
Uppskatta om du inte minns exakt 
 
10. Om du tänker på den/dem du har haft samlag med under de senaste 6 månaderna, vem/vilka har det 
varit? 
 
o Endast kvinnor 
o Endast män 
o Oftast kvinnor, ibland män 
o Oftast män, ibland kvinnor 
o Någon/några som varken uppfattar sig som man eller kvinna 
 
11. Med hur många partners totalt har du haft samlag (vaginalt och/eller analt) de senaste 6 månaderna? 
Uppskatta om du inte minns exakt. 
 
o 0 
o 1 
o 2 
o 3 
o 4 
o 5 
o 6 
o 7 
o 8 
o 9 
o 10 eller fler 
 
12. Med hur många personer har du haft skyddat samlag (vaginalt och/eller analt) de senaste 6 månaderna? 
Med skyddat menas samlag med kondom varje gång och under hela samlaget. 
o 0 
o 1 
o 2 
o 3 
o 4 
o 5 
o 6 
o 7 
o 8 
o 9 
o 10 eller fler 
 
13. Använde du kondom vid senaste samlaget (vaginalt och/eller analt)? 
 
o Ja 
o Nej 
o Kommer inte ihåg 
 
14. Hur ser din typiska kondomanvändning ut 
 
o Aldrig 
o Sällan 
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o Ungefär varannan gång 
o Oftast 
o Alltid 
 
15. Använder du något preventivmedel förutom kondom (p-stav, spiral, p-ring, p-piller, minipiller, annat)? 
 
o Ja 
o Nej 
 
16. Har du någon gång i livet haft en könssjukdom (klamydia, gonorré, mycoplasma, herpes, kondylom, 
annat)? 
 
o ja  
o nej 
o vet inte/har aldrig testat mig 
 
17. Hur ofta brukar du lämna prov för könssjukdomar? 
 
o Jag har aldrig testat mig 
o Jag testar mig ungefär en gång per år 
o Jag testar mig 2-3 gånger per år 
o Jag testar mig 4-5 gånger per år 
o Jag testar mig efter varje gång jag har haft oskyddat samlag  
 
18. Har du varit gravid eller gjort någon gravid?  
 
o ja  
o nej  
o vet inte 
 
19. Har du någon gång under de senaste 6 månaderna haft sex med någon som du egentligen inte ville ha 
sex med? 
 
o Nej 
o Ja 
o Vill inte svara på frågan 
 
20. Har du någon gång under de senaste 6 månaderna ställt upp på någon typ av sex som du egentligen inte 
ville ha eller efteråt ångrat att du ställde upp på? 
 
o Ja 
o Nej 
o Vill inte svara på frågan 
 
21. Har du någon gång under de senaste 6 månaderna haft sex med någon första gången ni träffades? 
 
o Nej 
o Ja, 1 gång 
o Ja, 2 gånger 
o Ja, 3 gånger  
o Ja, 4 gånger  
o Ja, 5 gånger 
o Ja, 6 gånger eller fler 
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22. Har du någon gång under de senaste 6 månaderna haft oskyddat samlag (vaginalt och/eller analt) med 
någon första gången ni träffades? 
 
o Nej 
o Ja, 1 gång 
o Ja, 2 gånger 
o Ja, 3 gånger  
o Ja, 4 gånger  
o Ja, 5 gånger 
o Ja, 6 gånger eller fler 
 
23. Hur ofta har du under de senaste 6 månaderna varit påverkad av alkohol eller andra droger när du har 
haft sex med en tillfällig partner? 
 
o Aldrig 
o Sällan 
o Ungefär varannan gång 
o Oftast 
o Alltid 
o Jag har inte haft sex med en tillfällig partner de senaste 6 månaderna 
 
24. När jag har sex med andra klarar jag alltid av att bestämma över vilken typ av sex jag själv vill ha 
 
o ja alltid 
o ja oftast 
o Ungefär hälften av gångerna 
o sällan 
o aldrig 
 
25. Vilken typ av sex jag har med en annan person bestäms mer av den andra personen än av mig? 
 
o ja alltid 
o ja oftast 
o Varken eller 
o sällan 
o aldrig 
 
26. Jag är bekymrad över hur jag blir bedömd som sexpartner? 
 
o Instämmer helt 
o Instämmer delvis 
o Varken eller 
o Instämmer inte alls 
 
27. Om jag har en ny eller tillfällig relation och vill att vi använder kondom som skydd så har jag mod att be 
om det? 
 
o Ja, alltid 
o Oftast 
o Sällan 
o Nej, aldrig 
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Frågeformulär som skickas ut efter 3 månader/ 6 månader 
Introduktionstext: Hej igen. Dessa 19 frågor syftar till den tid som har gått sedan du senast svarare på frågor i 
”appen”, alltså då studien startade för 3 månader sedan. Dina ärliga åsikter och svar är viktiga. Vi lägger inga 
moraliska värderingar i hur du svarar på frågorna. Din identitet är helt skyddad. 
 
1. Vad stämmer bäst in på hur du lever just nu 
o Singel 
o Fast relation 
o Dejtar en person men har inte en fast relation 
o Dejtar två eller flera men har inte en fast relation 
o Har en återkommande sexpartner 
o Har flera återkommande sexpartners 
 
2. Har du under de senaste 3 månaderna haft en pågående sexuell relation med en person som under 
samma period haft sex med någon annan än dig? 
o Nej 
o Nej, jag tror inte det 
o Ja 
o Ja, det tror jag 
o Jag har ingen sexpartner 
 
3. Om du tänker på den/dem du har haft samlag med under de senaste 3 månaderna, vem/vilka har det 
varit? 
 
o Endast kvinnor 
o Endast män 
o Oftast kvinnor, ibland män 
o Oftast män, ibland kvinnor 
o Någon/några som varken uppfattar sig som man eller kvinna 
o Jag har inte haft samlag under de senaste 3 månaderna 
 
4. Med hur många partners totalt har du haft samlag (vaginalt och/eller analt) de senaste 3 månaderna? 
Uppskatta om du inte minns exakt. 
 
o 0 
o 1 
o 2 
o 3 
o 4 
o 5 
o 6 
o 7 
o 8 
o 9 
o 10 eller fler 
 
5. Med hur många personer har du haft skyddat samlag (vaginalt och/eller analt) de senaste 3 månaderna? 
Med skyddat menas samlag med kondom varje gång och under hela samlaget. 
 
o 0 
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o 1 
o 2 
o 3 
o 4 
o 5 
o 6 
o 7 
o 8 
o 9 
o 10 eller fler 
 
6. Använde du kondom vid senaste samlaget (vaginalt och/eller analt)? 
 
o Ja 
o Nej 
o Kommer inte ihåg 
 
7. Använder du något preventivmedel förutom kondom (p-stav, spiral, p-ring, p-piller, minipiller, annat)? 
 
o Ja 
o Nej 
 
8. Har du någon gång under de senaste 3 månaderna haft en könssjukdom (klamydia, gonorré, 
mycoplasma, herpes, kondylom, annat)? 
 
o ja  
o nej 
o Vet inte/har inte testat mig 
 
9. Har du under de senaste 3 månaderna testat dig för könssjukdomar? 
 
o Ja en gång 
o Ja flera gånger 
o Nej 
o Jag kommer inte ihåg 
 
10. Har du de senaste 3 månaderna varit gravid eller gjort någon gravid?  
 
o ja  
o nej  
o vet inte 
 
11. Har du någon gång under de senaste 3 månaderna haft sex med någon som du egentligen inte ville ha 
sex med? 
 
o Nej 
o Ja 
o Vill inte svara på frågan 
 
12. Har du någon gång under de senaste 3 månaderna ställt upp på någon typ av sex som du egentligen inte 
ville ha eller efteråt ångrat att du ställde upp på? 
 
o Ja 
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o Nej 
o Vill inte svara på frågan 
 
13. Har du någon gång under de senaste 3 månaderna haft sex med någon första gången ni träffades? 
 
o Nej 
o Ja, 1 gång 
o Ja, 2 gånger 
o Ja, 3 gånger  
o Ja, 4 gånger  
o Ja, 5 gånger 
o Ja, 6 gånger eller fler 
 
14. Har du någon gång under de senaste 3 månaderna haft oskyddat samlag (vaginalt och/eller analt) med 
någon första gången ni träffades? 
 
o Nej 
o Ja, 1 gång 
o Ja, 2 gånger 
o Ja, 3 gånger  
o Ja, 4 gånger  
o Ja, 5 gånger 
o Ja, 6 gånger eller fler 
 
15. Hur ofta har du under de senaste 3 månaderna varit påverkad av alkohol eller andra droger när du har 
haft sex med en tillfällig partner? 
 
o Aldrig 
o Sällan 
o Ungefär varannan gång 
o Oftast 
o Alltid 
o Jag har inte haft sex med en tillfällig partner de senaste 3 månaderna 
 
16. När jag har sex med andra klarar jag av att bestämma över vilken typ av sex jag själv vill ha? 
 
o ja alltid 
o ja oftast 
o Ungefär hälften av gångerna 
o sällan 
o aldrig 
 
17. Vilken typ av sex jag har med en annan person bestäms mer av den andra personen än av mig? 
 
o ja alltid 
o ja oftast 
o Varken eller 
o sällan 
o aldrig 
  
18. Jag är bekymrad över hur jag blir bedömd som sexpartner? 
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o Instämmer helt 
o Instämmer delvis 
o Varken eller 
o Instämmer inte alls 
 
19. Om jag har en ny eller tillfällig relation och vill att vi använder kondom som skydd så har jag mod att be 
om det? 
 
o Ja, alltid 
o Oftast 
o Sällan 
o Nej, aldrig 
 
 
 
 
 
 
 
 
 
 
 
 
 
